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ABSTRACT
ATTACHMENT ABILITY AND MELANOMA INHSBSTORY ACTIVITY
MRNA EXPRESSION LEVEL CHANGES IN MURINE B16-F10
MELANOMA CELLS POST NANOSECOND ELECTRIC PULSES
Hongxia Jia
Old Dominion University, 2013
Director: Dr. R. James Swanson
The effects of high-voltage nanosecond electric pulses (nsEPs) on metastatic
melanoma are still unclear. Hence, we applied one, two, three, and four 300 ns
40 kV/cm pulses to murine B16-F10 melanoma cells. Cell attachment ability was
determined by comparing the number of floating cells and the percentage of
attached cells. Melanoma inhibitory activity (MIA) is a secretory protein that is
highly correlated with the malignancy and metastasis of malignant melanomas.
We used MIA as our target to evaluate the effect of nsEPs on metastasis. Pulsed
(experimental) and unpulsed (control) cells were incubated at 37°C under a 5%
C 0 2 atmosphere. To determine cell attachment ability, the culture medium
supernatant and attached cells were collected at 6, 12, 18, and 24 h after a single
pulse. The live, dead, and total floating cells in the culture medium supernatant
were counted. In addition, the live, dead, and total attached cells were counted
after multiple pulses. Total RNA was extracted from the attached cells and
reverse transcribed into cDNA. The MIA mRNA expression levels were measured
using the cDNA temple via quantitative real-time PCR, with /3-actin as the
internal control. The experiment was repeated three times (n=3). The results
show that a single pulse did not affect the cell attachment ability, cell morphology,
and the MIA mRNA expression levels (P=0.8058). Two pulses significantly
decreased the cell attachment ability (P=0.014), cell viability (P<0.0001), and
changed the cell morphology, but did not change the MIA mRNA expression. The
three-pulse and the four-pulse treatments significantly decreased the cell
attachment ability (P=0.004, 0.00002, respectively), cell viability (P<0.0001),
changed the cell morphology, and increased the MIA mRNA expression levels
within the first 12 h (P=0.041, 0.001, respectively). These indices were almost
normal at 24 h after pulsing. We speculate that the two-, three-, and four-pulse
treatments would be optimal for treating melanoma metastasis, whereas the

single pulse treatment was not. Therefore, nsEPs provides a great opportunity
for treating metastatic melanomas.
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CHAPTER 1

INTRODUCTION

1.1 CANCER MALIGNANCY
The diagnosis of cancer malignancy is based on anaplasia, invasiveness,
and metastasis (Mostofi et al., 1999). Anaplasia is the dedifferentiation of normal
cells, wherein they loss structural and functional differentiation, and fail to
develop recognizable growth patterns. Invasiveness is the ability to infiltrate and
destroy the surrounding tissue. The invasiveness of cancer cells is related to
intercellular adhesion (Turner and Sherratt, 2002). Metastasis is the movement of
cancer cells from one original tissue or organ to other tissues or organs. Various
types of cancer have different metastatic levels (Vinay et al., 2004).
1.2 MELANOMA
1.2.1 GENERAL CHARACTERISTICS OF MELANOMA
Melanomas are a malignant skin cancer derived from melanocytes.
Melanomas are less common than other skin cancers, but they account for the
majority of skin cancer deaths. Melanomas mainly occur in skin, but they can
occur in any tissue that contains melanocytes. Melanomas derived from
melanocyte. Most melanomas are dark pigmented, because of the melanin
secreted by abnormal melanocytes. However, some melanomas called melanotic
melanomas, are unpigmented.
The incidence rates of melanoma among Caucasians is 31.6 per 100,000
men and 19.9 per 100,000 women, much higher than Black and Asians/Pacific
Islanders at 2 per 100,000 men or women (Howlader et al., 2012). Althogh the
incidence rates of most cancer sites are decreasing, the incidence rates of
melanomas among men and women are increasing (Siegel et al., 2013). About
61,300 cases of melanoma in situ are expected to be diagnosed in 2013 (Siegel
et al., 2013).
The dissertation journal model is Cell.
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1.2.2 MELANOMA METASTASIS
Numerous reports have shown the increasing incidence of melanoma
metastasis and recurrence in both children and adolescents in Western
Countries(Kopf et al., 1982; Rigel et al., 1996; Hoang and Eichenfield, 2000;
Yeung, 1994). Sufficient evidence from case studies have shown that human
melanoma metastasize to various organs in the human body, including the
bladder (Toledano et al., 2009), brain (Cemil et al., 2008; Takahashi et al., 1990),
breasts (Loffeld and Marsden, 2005), colon (Lesur et al., 2009), heart (Chrissos
et al., 2008; Houmsse et al., 2004), liver (Arunkumar et al., 2001), lungs (Shin
et al., 2011), nerves (Hashemi et al., 2009), penis (Kurul et al., 2006), placenta
(Perret-Court et al., 2010), spleen (Buzbee and Legha, 1992), thyroid gland
(Punda et al., 2010), and uterus (Luxman et al., 1997), among others. The most
frequent target organs of metastases are the bones, brain, liver, and lungs
(Langley and Fidler, 2011). The median survival for metastatic melanomas is
very poor, only ranging from 2 to 8 months (Jemal et al., 2008) with only 5% of all
patients surviving more than 5 years. Thus, metastatic melanomas are one of the
most uncontrollable and mentally devastating cancers.
1.3 MELANOMA INHIBITOR ACTIVITY (MIA)
1.3.1 FUNCTION OF MIA
The growth of human malignant melanoma cells can be regulated by
autocrine and paracrine growth factors in a culture supernatant (Bogdahn et al.,
1989). MIA protein has been isolated from the culture supernatant of human
melanoma cells lines and it potently suppresses the growth of malignant
melanoma cells by inhibiting DNA synthesis and causing cell rounding (Blesch
et al., 1994). MIA mRNA was reported as expressed in non-metastatic melanoma
cell lines but was absent in highly metastatic cell lines (van Groningen et al.,
1995). However, subsequent analyses have shown contrasting results. High
serum MIA levels correspond to high malignancy and metastasis in malignant
melanoma patients (Bosserhoff et al., 1997a). In mice, the invasion of lung
metastasis is strictly correlated with levels of MIA secretion (Bosserhoff et al.,
2001). MIA overexpression is correlated with higher rates of extravasasion and
invation (Guba et al., 2000).
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MIA has been independently identified from primary bovine chondrocytes and
cartilage tissue as cartilage-derived retinoic acid-sensitive protein (CD-RAP),
which is necessary for cartilage development and maintenance (Dietz and
Sandell, 1996). Hence, the term MIA/CD-RAP refers to MIA. MIA is involved in
malignant melanoma progression and spread by mediating cellular detachment
from extracellular matrix proteins, including fibronectin (Bosserhoff et al., 2003)
and integrin (Bauer et al., 2006). MIA is also expressed in breast cancer
(Bosserhoff et al., 1999), gastric cancer (Aung et al., 2005), and pancreatic
cancer (El Fitori et al., 2005). Low doses of MIA enhance mesenchymal stem cell
migration, whereas high doses inhibit cell migration (Tscheudschilsuren et al.,
2006). Extremely low levels of MIA mRNA are present in various normal and
neoplastic cell types (De Vries et al., 1999).
MIA is a highly specific and sensitive marker for clinically follow-up and
therapy monitoring (Bosserhoff and Buettner, 2002). Thus, we choose to
evaluate MIA as a mediator for melanoma malignancy and metastasis.
1.3.2 STRUCTURE OF MIA
The human MIA precursor has 131 amino acids. The secreted MIA is 11 kDa,
consisting of 108 amino acids, and forms a small globular protein via two
intramolecular disulfide bonds (Blesch et al., 1994). Src (sarcoma) homology 3
(SH3) is a small protein containing 64-77 amino acids. They form five or six
/5-strands producing two anti-parallel /5-sheet. Multidimensional NMR shows
that MIA adopts Src homology 3 (SH3) domain-like folds: two perpendicular,
antiparallel, three-strand, and 5-strand /5-sheets (Stoll et al., 2001). MIA has a
single-domain. The solution structure of human MIA protein is shown in Figure 1.
The PDB ID of human MIA protein is 1K0X. The folded core of MIA is rigid;
however, several loops that connect the /5-sheets have increased mobility,
indicating the extended interactions of SH3 domains (Stoll et al., 2003).The
mouse MIA gene is 1.5 kbp and consists of four exons (Bosserhoff et al., 1997b).
Mature mouse MIA has 130 amino acids. MIA dimerization was recently found to
be correlated with functional activity (Schmidt et al., 2012).
1.4 TREATMENT OF METASTATIC MALIGNANT MELANOMA
The most common treatment of melanoma is resection. For unresectable
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Figure 1. Solution Structure of Human MIA protein
Human MIA protein has 7 f3—sheets. It contains a SH3 subdomain. The N - and C -term inal end
have about 20 amino acids each which fold toward the SH3 subdomain.The picture was obtained
from Protein Data Bank.

malignant melanomas, other treatments that are clinically used include single
drug and multidrug chemotherapy (e.g., dacarbazine, hydroxyurea),
immunotherapy (e.g., interleukin-2, interferon-a), and biochemotherapy (e.g.,
dacabazin/interferon-a combination)(Mouawad et al., 2010).
Considering that the incidence of melanoma deaths continues to increase
despite the wide availability of surgical and chemical treatments and heightened
concerns regarding patient with tumor survival, novel treatments for inhibiting
metastasis progression, prolonging patient survival, and enhancing quality of life
are urgently necessary.
New alternative approaches using electric pulse treatment are being explored.
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Electrochemotherapy is an alternative treatment that combines drug therapy with
microsecond-scale electric pulses, which causes electropermeabilization (Kubota
et al., 2005). Irreversible electroporation is a non-thermal tumor ablation therapy
that uses continuous microsecond-scale pulses to permanently permeabilize the
cell membrane (Al-Sakere et al., 2007). Another treatment uses nsEPs to induce
apoptosis within the cancer cells (Schoenbach et al., 2007).
1.5 nsEPS
nsEPs are pulses with nanosecond durations. nsEPs have pulse rise times
that are much shorter than the redistribution time of plasma membrane lipid
bilayers. Thus, nsEPs penetrate the cell membrane and probable most organelle
membranes (Nuccitelli et al., 2009b). nsEPs cause small pores in the membrane
without significant heating. A single 300 ns electric pulse only deposits 0.2 Joule
(J) of energy and penetrates the membranes without significantly heating the
melanoma (Nuccitelli et al., 2006).
nsEPs generate intense nanosecond pulsed electric fields (nsPEFs), which
are widely used in many bioelectric applications (Romeo et al., 2010), for
example manipulating lipid nanopores in the cell membrane (Pakhomov et al.,
2009). One report showed that nsPEFs accelerate platelet aggregation (Zhang
et al., 2008). Our colleagues have also shown that murine B16-F10 melanoma
cells under nsPEFs therapy die through a combination of electrical effects (major)
and thermal effects (minor to negligible) (Xiao et al., 2011). Our previous
research showed that nsPEFs therapy initiates apoptosis in melanomas,
achieving completed remission without recurrence in mice (Nuccitelli et al.,
2009a). Despite the remarkable progression of nsPEFs research, metastatic data
on the link between the nsPEFs and malignant melanoma are still lacking. Thus,
we selected murine B16-F10 melanoma cells and the similar pulse condition (300
ns duration, 40 kV/cm power, but not 100 pulse number, 17 Hz lower frequency)
(Nuccitelli et al., 2009a) to study the changes in cancer malignancy or metastasis
at the low pulse numbers of, one, two, three, and four pulses in vitro. We chose
fewer pulses for the following reasons:
1. The final goal of this research is to determine a new method for treating
metastatic melanoma. If this method works, both metastatic melanoma
cells and normal tissue cells would necessarily be pulsed in vivo. We
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expect that metastatic melanoma cells would be killed or inhibited, whereas
the normal tissues would not.
2. To our knowledge, this study is the first to measure MIA after high-voltage
nsPEs treatment.We expect one of three possible results: inhibition,
stimulation, or no effect on MIA mRNA expression. Although, we hope to
show an inhibitory effect from this method, no effect would be a better
finding than stimulation because such a result would indicate that pulses at
least do not further aggravate melanomas.
3. In terms of research feasibility, pulsed melanoma cells must remain alive so
that total RNA may be extracted from melanoma cells, and MIA mRNA
expression can be measured. Based on the cell viability under similar pulse
conditions, 10 pulses would significantly increase trypan blue cell intake
(Ford et al., 2010). Thus, pulses fewer than 10 should suitably advance our
research.
1.6 nsEPS EFFECT ON CELL MEMBRANE
nsEPs cause long-lasting (minutes) cell membrane permeabilization in
mammalian cells and the gradual recovery could take 15 min (Pakhomov et al.,
2007a). Unlike classical electroporation conditions, nsEPs causes fewer and
smaller pores, as well as more rapid resealing rates (Beebe et al., 2003). The
maximum pore size of the cell membrane after nsEPs treatment is around 1 nm
(Pakhomov et al., 2009). This small pore size would not allow trypan blue go
through. Thus, nsEPs do not trigger the cell membrane to immediately uptake the
membrane-impermeable marker dyes, such as trypan blue and propidium iodide
(Pakhomov et al., 2007b; Thomas Vernier et al., 2004). Thus, trypan blue can be
used to test cell integrity and viability tests are still valid if all the pores are
resealed.
1.7 METHOD FOR MEASURING CHANGES IN ATTACHMENT ABILITY
Several methods are available for testing cell adhesion and attachment ability.
One method is called centrifugal force-based adhesion assays (Angres et al.,
1996). This assay tests cells bond for adhesion ability. A cell monolayer is
formed at the bottom of the microtiter well. Radioactively labeled cells are seeded
into the monolayer by centrifugation. Another microtiter with growth medium is
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mounted on top of the first microtiter, forming a sealed chamber. Afterward, the
sealed chamber is incubated, inverted, and centrifuged to dislocate the unbound
radioactively labeled cells from the monolayer. The sealed chamber is then
frozen and clipped into top, middle, and bottom layers. The radioactivity in the
three layers is measured, and the percentage of bound cells indicates the
adhesion ability.
The other method is using a standard physical agitation procedure to test cell
detachment ability (Zhu et al., 2002). This assay tests cell detachment for
adhesion ability. A layer of cell adhesion molecules, such as collagen I and
collagen IV, are spread on the surface of cell culture plate. Cells are seeded into
the plate and incubated for 24 h. The plate is then placed on a motorized shaking
table at 40 hertz for 10 min to 50 min. Afterward, the detached cells are collected
from the growth medium and counted using 3-(4,5-Dimethylthiazol-2-yl)-2,5diphenyltetrazolium bromide (MTT), which turns purple if the cells are alive and
yellow if the cells are dead. The percentage of cells that remain attached
indicates the adhesion ability.
The third method involves measuring the percentage of attached live cells
among the total number of live cells. The total number of cells includes the
floating cells in the growth media and the attached cells on the cell culture plate.
Cell number is counted using trypan blue on a hemocytometer. Trypan blue is a
large blue hydrophilic dye with two azo chromophores. Trypan blue is an acid
tetrasulfonated negatively charged dye. Trypan blue cannot enter cells unless
their cell membranes are broken. Clear or unstained cells indicate intact cell
membranes. The blue stained cells indicate damaged cell membranes. Normally,
trypan blue is used as a vital stain because live cells exclude trypan blue outside
the membrane, whereas dead cells allow trypan blue to penetrate the cell. Thus,
the trypan blue exclusion test is called trypan blue viability test. However, in
some special circumstances, such as pore formation, trypan blue intake does not
indicate cell death. Trypan blue can enter the cell if the pore is large enough.
Hence, the trypan blue exclusion test is called trypan blue uptake test. The pores
may last for several seconds, or minutes. The duration of pores formed by nsEPs
is still under development.
Cell adhesion includes cell attachment and cell detachment. The first two
adhesion assays determine cell detachment ability. The last adhesion assay tests
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cell attachment ability. In this study, we tested cell attachment ability using the
last adhesion test method. The number of live, dead, and total floating cells and
the percentage of live attached cells among the total live cells were used to
examine the changes in cell attachment ability after nsEPs.
1.8 CELL ATTACHING PROCESS
Changes in cell shape were observed during cell division based on the
time-lapse video recording of the dividing cells (Piel et al., 2001) (Figure 2). The
just-attached cells were round, and the cell contents moved from the center to
one end and then from one end to the opposite end, forming a spindle shape.
Afterward, the cell contents move from one end to the other end, forming an
umbrella shape. The cell began to grow and the cell contents spread out to more
area, forming a stellate or polygonal shape. Some cell contents move from one
process to another process, which leave the old processes as a spinous shape.
Finally, the cell rounds up again to divide.
This cell attachment process provides a useful tool for measuring changes in
cell attachment ability after pulse. We tested the cell attachment process of the
pulsed and unpulsed cells by photographing them at 6, 12, 18, and 24 h.
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Figure 2. CeSi A ttachm ent Process
(A) The cell after division. The cell is round.
(B) Cell contents move upward and downward. The cell becomes spindle shaped.
(C) Cell contents move to one end. The cell forms an umbrella shape.
(D) Cell grows and the cell contents spread out. The cell forms a star or polygonal shape. The cell
contents move towards the cell center, leaving two spines. DNA synthesis and the preparation of
cell division cause a large nucleus.
(E) One cell divided into two daughter cells. The daughter cells are round.
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1.9 METHOD FOR MEASURING MSA mRNA EXPRESSION LEVEL
Two methods are normally used to quantify mRNA expression level: northern
blot analysis and RT-qPCR. Northern blot analysis has three basic steps. The
first step is to separate the RNA sample through gel electrophoresis. The second
step is hybridizing the separated RNA sample bands with radioactive or
fluorescence-labeled RNA probes. The labeled RNA probe is specific, and only
binds to the target sequence. The third step is measuring the radioactivity or
fluorescent intensity of the probe-bound band in a gel image. However, northern
blot analysis requires large quantities of the RNA target in the sample and it is not
completely accurate.
RT-qPCR is the combination of reverse transcription (RT) and quantitative
(real-time) PCR (qPCR). Reverse transcription creates a single-stranded
complement DNA (cDNA) template from the mRNA. The cDNA template is then
amplified using a normal PCR process; however, the amplification detection is
special for qPCR.
Two types of dyes are used in q PCR. One is a fluorescent probe that
specifically binds to the target sequence and fluorescences only when they bind
to the target. The fluorescence intensity from the probes increases as the
amplification progresses because the probe binds to more o f the target
sequences. The other type is an intercalating dye, such as SYBR Green, which
only binds to double-stranded DNA, but not to single-stranded DNA. The
double-stranded DNA-SYBR Green complex absorbs light at 497 nm and emits
green light at 520 nm. The exact amount of cDNA is determined in terms of green
fluorescence.
Both types of dye can theoretically detect a single copy of the target cDNA.
The advantage of the probe method is its high specificity; however, it is very
expensive. The SYBR Green method is less expensive; however, it is less
specific because double-stranded DNA also fluorescences. However, if the PCR
reaction is very specific, i.e., it produces only the expected PCR product, the
SYBR Green method can also be highly specific.
For this study, we used SYBR Green RT-qPCR to measure MIA mRNA
expression levels. The single PCR product and its size were tested to ensure
PCR specificity.
Quantitative real-time PCR uses internal control, such as /3-actin, to
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normalize the target mRNA expression level. /?-actin forms cytoskeleton and is
involved in structure and motility of a cell. /3-actin is highly conserved and
generally represented in all most every tissue. /?-actin is formed by 375 amino
acids. The molecular weight of /?-actin is 42 kDa. Because of the stable
expression of /3-actin, it is well accepted to be the internal control of real-time
PCR.
1.10 METHOD FOR MEASURING PCR EFFICIENCY
The amplified sequence is called an amplicon. PCR efficiency is the doubling
of the amount of amplicon at each cycle. The theoretical PCR efficiency is 2,
which indicates the amount of amplicon doubles at each cycle. PCR efficiencies
ranging from 190 % to 210 % are satisfactory.
qPCR efficiency can be measured using two methods: the dilution or standard
curve method and the amplification curve method.
The dilution or standard curve method uses a dilution series of templates to
perform amplification. The quantity and Ct values of these amplifications are
plotted on a graph, which is called the standard curve. The linear regression
slope of the curve is used to calculate the PCR efficiency (Equation 1). Normally,
tenfold dilutions are much better than twofold dilutions because the regression
slope is confined to a smaller range (more accurate). The data for the standard
curve should be repeated at least three times. The ideal slope is -3.32, which
correlates to the PCR amplification efficiency of 2 (some researchers use 100%).
Efficiency = 1o(~ Slope }

0)

The standard curve method is simple and is traditionally used, but it needs a
large amount of the template to perform at least six tenfold dilutions (1, 10, 100,
1000, 10000, 100000). This requirement is impossible for our study because we
only have small amounts of the MIA cDNA template. After only three dilutions,
the Cq values would be out of 40 cycles.
The amplification curve method uses computer software to calculate PCR
efficiency for every individual qPCR. Software such as LinRegPCR and qpcR are
freely available to the public and accepted by journals. Both programs calculate
efficiency from the log linear phase of the qPCR fluorescence curve. LinRegPCR
is very easy to use in Windows system. It allows the manual adjustment of the
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upper and lower limits of the calculating range (Figure 31 on Page 77). The PCR
efficiency results can be exported to an Excel sheet, which is very easy to
analyze further. qpcR is a software package for R programing program that can
be used in Windows, Mac, and Linux systems. In qpcR, we must first choose the
best model to fit the raw fluorescence curve. We type in commands to calculate
the PCR efficiency (Page 79).
The advantage of both LinRegPCR and qpcR is that they need smaller
amounts of the template (theoretically one copy of template). LinRegPCR can be
partially adjust manually, but it can only be used in Windows. By contrast, qpcR
can be used on Windows, Mac, and Linux systems, but it cannot be manually
adjusted, and it can only be adjusted through commands.
The amplification curve method was used in this study because the amount of
MIA cDNA template was too low for the standard curve method. Both
LinRegPCR and qpcR were used to determine qPCR efficiency.
1.11 STATISTICAL METHOD FOR ANALYZING THE RESULTS
Different group means can be compared using a t-test and an analysis of
variance (ANOVA).
In the t-test, also called Student’s t-test, the test statistics follows a Student’s t
distribution if the null hypothesis is supported. T-tests are normally used to
compare two sets of data to determine whether they are significantly different
from each other. If the scale parameter is large enough, the t-test can also be
used for a normal distribution.
In ANOVA, the observed variance is partitioned into the components
attributed to different sources of variation. An ANOVA is used to determine
whether the means of at least two groups are equal or not. The different
treatments or experimental procedures are called factors. For example, the
treatment (pulse) and time points are two factors. ANOVA can be classified as
fixed, random, or mixed. For fixed ANOVA, the dependent factors are assigned to
the subjects. For random ANOVA, the dependent factors are randomLy applied
by the subjects. Mixed ANOVA is a combination of fixed and random ANOVA.
Using multiple t-test to compare means of multiple groups increases the
chance of type I error, wherein the null hypothesis is true but is rejected. Thus, an
ANOVA is used to compare two or more groups means. Follow-up tests such as
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Tukey’s test are used to compare two sets of data within the groups.
In this study, a two-factor fixed ANOVA and Tukey’s follow-up test were used
to compare the differences between the experimental group (pulsed group)
means and the control group (unpulsed group) means, as well as among the
means of four time points.
1.12 SIGNIFICANCE
High-voltage nsEPs are very useful for treating the melanoma in situ;
however, curable treatment of metastatic melanoma remains limited. Evidence
related to the effect of nsEPs on malignant melanomas is still inconclusive.
Furthermore, the subsequent influence of nsEPs on melanoma metastasis is
largely unknown. This study evaluates the effect of nsEP treatment (exposure)
on the malignancy and metastatic marker MIA in murine B16-F10 melanoma
cells. The results will enhance our understanding of the relationship of nsEP
treatment and its positive and negative effects on melanoma malignancy or
metastasis. Such information is critical for establishing proper nsEP treatments
that can inhibit melanoma metastasis, reduce melanoma malignancy in humans,
and increase patient with tumor survival.
Finding the relationship of nsEP treatment with melanoma malignancy and
with inhibiting metastasis may inspire research on a new field of melanoma
treatment.
1.13 INNOVATION
Our research is the first to study changes in MIA expression after applying
high-voltage nsEPs. This dissertation evaluates nsEPs from a fresh point of view,
which may yield a potential tool for treating melanoma metastasis. This research
will increase knowledge in applying nsEPs in cancer research. Considering
longer-term outcomes, this research may serve as a reference for future studies
on nsEPs pulsing conditions. The effective treatment of malignant melanoma will
significantly benefit public health. The next logical stage of research beyond this
current application is to establish several guidelines for studying the mechanism
of melanoma metastasis. The long-term goal of our laboratory is to develop and
apply a new treatment for controlling melanoma metastasis and reducing
melanoma malignancy. Completion of this research will allow us to obtain a better
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understanding of the nsEPs effect on melanoma malignancy and metastasis. In
the long run, understanding the interaction of nsEPs and melanoma during the
regulation of melanoma metastasis will (1) lead to the development of new
therapeutic modalities that activate melanoma responses and limit metastasis,
(2) identify novel metastasis regulators that could be exploited as anticancer drug
targets, and (3) identify melanoma responses that similarly control the
development of other medically important obligate pathogens.
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CHAPTER 2
MATERIALS AND METHODS

2.1 EXPERIMENTAL DESIGN
The design of this study was represented as shown in Figure 3.

Culture B16-F10 Murine melanoma cells, 4-8 passages

Pulse the cells and culture them in 24-well plate immediately

Collect cells and media after 6, 12, 18, and 24h
Cells
Extract total RNA

Cells and Media
Attachment ability test

Reverse transcription of total RNA into cDNA

Measure the MIA mRNA expression level by quantitative Real-time PCR

Figure 3. Experim ental Design Flow C hart
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2.2 CELL CULTURE
Frozen B16-F10 cells (ATCC® CRL-6475™) were kept in liquid nitrogen vapor
phase until it thawed to maintain their viability. The composition of the complete
growth medium is modified according to Product Information Sheet for ATCC®
CRL-6475™ (Table 1).

Table 1. C om position o f Com plete G row th M edium (500 mL) Receipt
Gradients (Abbrev., Source)
ATCC-formulated Dulbecco’s modi-

Catalog

Final Concentra-

Volume

No.

tion (Final %)

(mL)

30-2002

Base medium

430

Fetal bovine serum (FBS, GIBCO)

16141-061

10%

50

200 mM

25-005-CI

4 mM (2%)

10

30-001-Cl

100

10

fied Eagle’s medium (DMEM, ATCC)

L-Glutamine

(Mediatech,

lnc.)(Nuccitelli et al., 2009a)
5000 lU/mL Penicillin-5000 ^g/mL
Streptomycin

solution

(Mediatech,

I.U./mL/100

ug/mL (2%)

Inc.)

2.2.1 RECOVERY OF CRYOPRESERVED CELLS PROCEDURE
Recovery procedures were modified according to Product Information Sheet
for ATCC81 CRL-6475™. Approximately, 20 mL of fresh complete growth medium
was warmed in an incubator for at least 30 minutes to 1) warm up the medium to
prevent chilling the cells and 2) reach normal pH (7.0 to 7.6) to prevent killing the
cells under excessive alkalinity. The cap of the tube was loosened during the
warming in the incubator. The 37°C water bath was turned on at the same time.
When the water bath was ready, the frozen vial containing melanoma cells was
removed from the liquid nitrogen. The cells were then thawed through gentle
agitation in the 37°C water bath for approximately 2 minutes or until all the
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contents were thawed by holding the cap with forceps and maintaining the o-ring
of the vial was above the water level. The vial was removed from the water bath
and sprayed with 70% ethanol to prevent contamination.
In a culture hood, the vial content was transferred into a sterile 15 mL
centrifuge tube containing 9.0 mL of complete growth medium. The 15 mL
centrifuge tube (Corning, Catalog No. 430766) was spun at 125 x g (R=16 cm,
836 rpm, calculated via Equation 4) for 5 minutes on a low-speed centrifuge
machine. Approximately, 4.5 mL of complete growth medium was added into 25
cm2 culture flasks (LUX Scientific Corp., Catalog No. 5325). The supernatant
was then removed and discarded. The cell pellet was resuspended with 3 mL of
complete growth medium, and then dispensed into a 25 cm2 flask to obtain a total
volume of 7.5 mL. The flask was incubated at 37°C under a 100% humidified 5%
C 0 2 atmosphere in a water-jacketed cell culture incubator (NUAIR, model#
NU-4750). The cells were checked daily. The complete growth medium was
renewed every 2 to 3 days.
2.2.2 SUBCULTURE PROCEDURE
The subculture procedures were modified according to Product Information
Sheet for ATCC® CRL-6475™.Approximately 36 mL of complete growth medium
was warmed in a 50 mL centrifuge tube (Corning, Catalog No. 430921) in an
incubator for at least 15 minutes. The cap of the tube was loosened during the
incubation. About 5 mL of Trypsin-EDTA (0.25% Porcine Trypsin in HBSS, with
0.02% EDTA-2Na and without Ca and Mg, SAFC Biosciences, Catalog No.
59428C) was warmed for at least 15 minutes in a 15 mL centrifuge tube in an
incubator. The old culture medium was then removed and discarded.
To remove all traces of serum, which contains trypsin inhibitor, the cell layer
was rinsed with 2 mL of prewarmed Trypsin-EDTA. About 3 mL of prewarmed
Trypsin-EDTA solution was added to the flask, and the cells were observed under
a Nikon inverted microscope for 5 to 10 min until the cells were rounded and
dispersed. To avoid clumping, the cells were not be disturbed, such as hitting or
shaking, during detachment. Approximately 7 mL of prewarmed complete growth
medium was added to a total of 10 mL, and the cells were aspirated by gently
pipetting to prevent bubble formation and cell damage. About 29 mL of
prewarmed complete growth medium was added into a new 75 cm2 flask. About
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1 mL of cell suspension was added into the new flask, to a total of 30 mL. The
subculture ratio is 1:10. The new flask was then incubated at 37°C in a 100 %
humidified 5% C 0 2 atmosphere. The cells were subcultured every 3 days to 4
days or once the cells reached 90% confluence.
2.2.3 CRYOPRESERVATION PROCEDURE
The cryopreservation procedures were modified according to ATCC® Animal
Cell Culture Guide.The cell culture was checked for contamination with bacteria,
mycoplasma, fungi, and viruses immediately before cryopreservation. The
cryoprotectant medium consisted of complete growth medium with 5% (v/v)
DMSO (Mediatech Inc., Catalog No. 25-950-CQC). The cells were collected via
Trypsin-EDTA treatment and gently centrifuged (5 minutes at 125x g). Afterward,
the cells were resuspended in the cryoprotectant medium.
The cell concentration was adjusted from 1 x106 to 5 x 1 0 6 viable cells/mL
using a hemocytometer. CryoTube vials (Thermo Scientific, Catalog No. 375353)
were labeled with ’Mouse Melanoma’, passage number, date, and contributor.
Then, 1 mL of cell suspension was added into each of the vials and the cap was
closed. The cells were then allowed to equilibrate in the cryoprotectant medium
at room temperature for at least 15 minutes, but no longer than 40 minutes.
Approximately, 91 % of isopropyl alcohol was added to the fill line on the
Nalgene® Mr. Frosty® Cryo 1°C Freezing Container (Thermo Scientific, Catalog
No. 5100-0001). The tube holder was carefully replaced onto the container.
CryoTube vials containing cells were placed into the holes in the tube holder. The
freezing container was placed at the bottom of a -8 0 °C freezer, and left
undisturbed for 24 h. The frozen vials were then quickly transferred from the
frozen container into the vapor-phase of liquid nitrogen tank for long time storage.
2.3 CELL COUNTING/VIABILITY ASSAY
Cell counting and viability assay were carried out using a hemocytometer (AO
Scientific Instruments, Bright-line®). The procedures were modified according to
ATCC® Animal Cell Culture Guide. The media of the pulsed and unpulsed cells
were collected at 6, 12, 18, and 24 h after nsEPs. Cell viability was measured via
the following procedures. Exactly 50 /A. of cell suspension was mixed (1:1) with
50 fiL of 0.4% (w/v) trypan blue solution in normal saline (Mediatech Inc., Catalog
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No. 25-900-CI). The mixture was then incubated for 2 min to 5 min. The
hemocytometer was cleaned, dried, and assembled with the cover slip. Exactly
100 fxL of cell mixture was loaded onto the edge of each of the two counting
chambers. The cell mixture was drawn automatically into the counting chamber
through capillary action.
The hemocytometer was placed under a Nikon inverted microscope and the
cells were viewed at 100xmagnification. Nonviable cells was stained blue and
viable cells remained unstained (transparent or clear). The number of viable and
nonviable cells in the squares in the four corners and the square in the center
were counted and recorded. The number of cells was the average of these five
areas. The average number in the top section and the bottom section were added
and multipled by 104 cells/mL. Cell viability was calculated using Equation 2:
^
• , ».., /n/,
Number of viable cells
„ __
C e llv labill.y ( % ) = Tota|num berofce||s x 100%

(2)

2.4 PULSE GENERATORS

Resistors

Charging
device

Spark

Capacitors

switch
D Cuvette

Figure 4. Pulse Form ing Network
Pulse forming network is formed by two parallel circuits. One circuit includes the charging device,
resistors, and capacitors. The other circuit includes the same capacitors, the biological sample in
the cuvette, and a switch. The figure has been modified (Beebe et al., 2010).
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Pulse generators are electronic equipments used for generating pulses. In
this study, two 300-nanosecond pulse generators were used. One pulse
generator based on the pulse forming network (Beebe et al., 2010) was designed
in the Frank Reidy Research Center for Bioelectrics, and the assembly was
modified by Dr. Yeong-Jer (Jack) Chen. This pulse generator for single pulse
consists of charging device, resisters, inductors, high-voltage capacitors, and
switch arranged in a pulse forming network configuration (Figure 4). Seven pairs
of high-voltage capacitors (Figure 5A) were charged through five resistors to 4
kV. The capacitors were then discharged by a spark gap switch into a 0.1 cm
electrode gap cuvette (Figure 5B) to generate a single 300 ns 40 kV/cm pulse.
The high voltage across the cells was tracked using a high-voltage probe
(Tektronix, P6015A), and the voltage (Figure 5C) was monitored using a digitizing
oscilloscope (Tektronix, TDS3052). The pulse wave shown in this study has a
sharp peak caused by the low resistance of the resistors around the cuvette. This
peak in electric current also went through the cells.
To modify the pulse wave into a more square shape without peaks, another
300 ns pulse generator for multiple pulses was designed in the Frank Reidy
Research Center for Bioelectrics, and the assembly was modified by Dr. Shu
Xiao. This pulse generator employs a transmission line architecture. The
transmission line included five parallel cables, each with an impedance of 50 f l
The total impedance of the five parallel cables was 10 f2. The pulse duration was
proportional to the length of the cable. The longer the cable is, the higher the
capacitance it has, thereby prolonging the pulse it delivers. The charges were
stored in the cables and released once they were connected to the cuvette by a
high-voltage switch. The high voltage across the cuvette was monitored and
recorded with a digitizing oscilloscope (Tektronix, TDS 380) (Figure 6). The pulse
wave shown in this study was nearly a rectangular, which had few and much
lower peaks. The frequency of the pulses generated from this pulser was about
17 Hz. This improvement significantly reduced the unnecessary electric current
after the nsEPs and allowed the cells to be pulsed more accurately.
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Figure 5. Single Pulse G enerator
(A)Experimental setup. The charging device (not shown), resistors, and capacitors with inductors
were connected in a circuit. The rod of the spark gap switch was manipulated by hand by obtaining
the switch toward the capacitors. The electrical breakdown of the air will close the parallel circuit,
which triggered the capacitors to charge the cells.
(B) Bio-Rad Gene Pulser® cuvette with 0.1 cm electrode gap, containing 90 /xL of PBS (1 x 1077mL
cell suspension was not shown in this picture).
(C) A single pulse wave (300 nanoseconds, 4 kV) was monitored using an oscilloscope.

Switch (— ■"
Pulsing Cuvette

Figure 6. Multiple Pulses Generator
(A) Experimental setup. The charging device (power), transmission lines were connected in a cir
cuit. The switch was manipulated using the red button on the power panel board. The electrical
breakdown of the air between the switch would close the parallel circuit, which triggered the trans
mission lines to charge the cells.
(B) Bio-Rad Gene Pulser® cuvette with 0.1 cm electrode gap was in the cuvette socket. The cuvette
contained 120

of cell suspension (1 x1 0 7/mL).

(C) A single pulse wave (300 nanoseconds, 4 kV) was monitored using an oscilloscope.
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2.5 NANOSECOND PULSED ELECTRIC FIELD TREATMENT
Cell suspension was prepared using Trypsin-EDTA treatment. Cells for each
replication were from different cell culture flask. The cells were gently centrifuged
at 125xg for 5 minutes, and then resuspended in Dulbecco’s PBS (Sigma,
Catalog No. D8537). Cell concentration was adjusted to 1 x 1 0 7 using a
hemocytometer. Exactly 90 iA. (for single pulse) or 120 iA. (for multiple pulses) of
cell suspension was added into the Gene Pulser® cuvette (Bio-Rad, Catalog No.
165-2083).
The cuvettes in the single-pulse groups were pulsed once for 300 ns at 40
kV/cm using the single pulse generator. The cuvettes in the multiple pulses
groups were pulsed twice, thrice, or four times for 300 ns at 40 kV/cm using the
multiple pulses generator. Control groups were loaded into the cuvettes without
pulsing. The cell suspension was then transferred into a 1.5 mL Snap Seal
graduated microtube (GeneMate, Catalog No. C-3262-1). The cells were gently
centrifuged at 125xg for 5 minutes. The supernatant was removed and
discarded. Afterward, the cells were resuspended in 1 mL of complete growth
medium. The cell resuspension was transferred into a well of a 24-well cell
culture plate (Corning Inc., Catalog No. 3524). Eight tubes of cell resuspension
were transferred into each plate (Figure 7 and 8). The 24-well plate was
incubated at 37°C under a 100 % humidified 5% C 0 2 incubator. Individual 24-well
plates were used. Each experiment was repeated three times (n=3). For safety
concern, the power for the charger was turned off after each pulse. The voltage
and ampere of the pulse generator were returned to zero after each experiment.
2.6 SAMPLE COLLECTION FOR RNA EXTRACTION
At 6, 12, 18, and 24 h after pulsing, the growth media were removed and kept
for cell counting from the corresponding well (Figure 7) for single pulse treatment.
Considering the cells harvested for subsequent experiments were collected 6
hours earlier, the cells harvested later were disturbed. To prevent this
disturbance, another cell setups were used (Figure 8) for multiple pulses
treatment, so that the cells harvested at different time points remained
undisturbed. Exactly 300 /A. of RNAprotect Cell Reagent was added to the cell
layer. The cells detached after the addition of the RNAprotect Cell Reagent. No
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PBS rinsing or Trypsin-EDTA treatment was necessary. The Attached cells were
suspended through gentle pipetting. The mixture was then stored at -20°C. The
mixture can be stored for years without significant RNA degradation. The mixture
was used within 1 week.

Experiment group: after a single pulse
C (,6 hours

12 hours

18 hours

24 hours! f.
V*

Control gro5p: unpulsed

Figure 7. Samples arranged in a 24-weil plate fo r s in g le pulse
The cells were seeded immediately after a single pulse in four wells, as the single pulse group
(upper row) and four wells were used as the control group (lower row). The wells were incubated
fo r 6 , 12,18, and 24 h, respectively. A shortcoming of this arrangement was that the cells harvested
at later hours were disturbed by the manipulation of the cells harvested at the earlier hours. The
culture medium was complete growth medium.
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Control

2'Rulses 3 Pulses

4 Pulses
Extraction
____

Cell Number Counting

Figure 8. Samples arranged in a 24-well plate for multiple pulses
The cells were seeded immediately after multiple pulses and cultured until harvested at 6 h. The
cells from the control, as well as the two-, three-, and four-pulse groups were seeded into the upper
row for subsequent total RNA extraction and were seeded in the lower row for cell counting. The
cells were arranged at 12, 18, and 24 h, similar to that for 6 h, using separate 24-well plates. This
arrangement prevents disturbance of the cells during subsequent harvesting. The culture medium
was complete growth medium.
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2.7 LONG-TERM CELL VIABILITY TEST
About 1.2x 106 cells were pulsed two, three, or four times for 300 ns at 40
kV/cm. After pulsing, the cell suspension was immediately transferred into
24-well plate for culture, as previously described. After 6, 12, 18, 24 h, the
attached cells were harvested using trypsin-EDTA treatment, whereas the
floating cells were counted under trypan blue staining. The cells were mixed 1:1
with 0.4% trypan blue. The attached cells and floating cells were counted, and
the percentage of viable cells was calculated, as previously described. This
experiment was repeated three times (n=3).
2.8 TOTAL RNA EXTRACTION AND DNA ELIMINATION
Total RNA extraction and DNA elimination were carried out using an RNeasy
Protect Cell Mini Kit (Qiagen, Catalog No. 74624). The tips and tubes were
Nuclease-free. RNaseZap™ (Sigma, Catalog No. R2020-250mL) was sprayed in
the working area to remove RNase contamination. The procedures were
referenced from RNeasy® Plus Mini Handbook. The mixture of the cells and
RNAprotect Cell Reagent was centrifuged for 5 minutes at 5000 xg (R=6 cm,
8634 rpm) in a 1.5 mL centrifuge tube using a Spectrafuge machine. The growth
media were removed completely by pipetting. The cell pellet was loosened by
flicking the tube. Then, 350 /j,L of Buffer RLT Plus was added to the cell pellet.
The cell pellet was dissolved completely by vortexing and then subjected
immediately to the next step. The lysate was pipetted directly into a QIAshredder
spin column placed in a 2 mL collection tube, and then centrifuged for 2 minutes
at full speed (R=6cm, 10000 rpm).
The homogenized lysate was transferred into a gDNA Eliminator spin column
placed in a 2 mL collection tube. The spin column was then centrifuged for 30
seconds at >8000xg (>10000 rpm). Afterward, the column was discarded, and
the flow-through was saved. One volume of 70% ethanol was added to the
flow-through, and mixed well by pipetting, without centrifugation. Up to 700 n L of
the mixture, including any precipitate that formed, was transferred to an RNeasy
spin column placed in a 2 mL collection tube. The lid was closed gently, and the
spin column was centrifuged for 15 seconds at > 8 00 0xg (>10000 rpm). The
flow-through was then discarded.
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Up to 700 pL of Buffer RW1 was added to the RNeasy spin column. The lid
was closed gently, and the spin column was centrifuged for 15 seconds at
>8000xg (>10000 rpm) to wash the spin column membrane. The flow-through
was discarded. Approximately, 500 p L of Buffer RPE was added to the RNeasy
spin column. The lid was closed gently, and the spin column was centrifuged for
15 seconds at >8000xg (>10000 rpm) to wash the spin column membrane. The
flow-through was discarded. Then, 500 pL of Buffer RPE was added to the
RNeasy spin column. The lid was closed gently, and the spin column was
centrifuged for 2 minutes at > 80 00 xg (>10000 rpm) to wash the spin column
membrane. The RNeasy spin column was placed in a new 2 collection tube, and
the old collection tube with the flow-through was discarded. The spin column was
centrifuged at full speed (>10000 rpm) for 1 minute. The RNeasy spin column
was placed in a new 1.5 mL collection tube. Then, 30 (A. of RNase-free water
was added directly to the spin column membrane. The lid was closed gently, and
the spin column was centrifuged for 1 minute at > 8 0 0 0 xg (>10000 rpm) to elute
the RNA. The last step was repeated using the eluate from the last step. The
collection tube was reused from the last step.
2.9 PURITY AND QUANTIFICATION OF RNA
The purity and quantification of the extracted total RNA were carried out using
NanoDrop 2000 spectrophotometer (Thermo Scientific, Catalog No. ND 2000) in
Dr. David Gauthier’s laboratory. For total RNA extraction sample, a 260/280 ratio
of 2.0 is generally accepted as ’’pure”. A 260/A 280 ratios ranging from1.8 to 2.1
were considered ’’pure” RNA in this study. The readings were valid if A 26o>0.15 at
a neutral pH. Nuclease-free water, which was used to dilute the RNA, was used
to calibrate the spectrophotometer. The RNA concentration was determined by
measuring the absorbance at 260 nm (A26o) and determined using the
spectrophotometer. The procedures were modified according to Thermo
Scientific NanoDrop Spectrophotometers Nucleic Acid handbook.
NanoDrop 2000 software for Windows was used to quantify RNA. One
microliter of Nuclease-free water was loaded onto the lower measurement
pedestal and the sampling arm was lowered. The ’’Blank” button in the software
was used to measure the nuclease-free water and the references spectrum was
stored into an external hard drive. The ’’Measure” button of the software was
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used to perform the detection. After the measurement, a dry Kim wipe
(Kimberly-Clark, Catalog No. 34155) was used to remove the liquid from both the
top and bottom measurement surfaces. The blank result should be a straight line
below 0.04 Abs from the baseline at 260 nm. If not, this step must be repeated.
After the blank measurement was completed, the sample name was entered in
the Sample ID box, and the sample type was set to RNA. One microliter of the
total RNA extraction sample was pipetted onto the lower measurement pedestal,
the sampling arm was lowered, and the ’’Measure" button was clicked. After the
measurement, a dry Kim wipe was used to remove the sample from both the top
and bottom measurement surfaces. The pipette tips were changed for the next
measurement. Calibration between samples was unnecessary.
2.10 TOTAL RNA INTEGRITY TEST
The integrity of the total RNA was checked via natural agarose gel
electrophoresis. Because 28S and 18S rRNA are highly conserved RNAs, we
chose them as a marker to evaluate RNA integrity. If the total RNA was intact, the
ratio of the light intensity of the 28S rRNA band to that of the 18S rRNA band
should be approximately 2:1. About 0.5 g of agarose was mixed with 50 mL
1 xTris/Borate/EDTA (TBE) in a 250 mL Erlenmeyer flask. The mixture was
microwaved for 30 seconds or until the liquid was clear, which indicates complete
dissolution of the agarose. The mixture was cooled for 1 min, and 5 yuL of SYBR®
Safe DNA gel stain was added to the mixture. The contents of the flask were then
swirled and the flask was cooled under tap water until it could be hanled safely.
The bottom of the gel cassette was adjusted to make it level and allow the gels to
have a uniform thickness. The gel mixture was then poured into the gel cassette
and a comb was placed to form eight 10 fA. wells in the gel.
The gel was cooled at room temperature for 45 min and the comb was
removed carefully without break the wells. The gel was then placed in a Mini-Sub
Cell GT System (Bio-Rad, Catalog No. 170-4466) powered by PowerPac™ Basic
Power Supply (Bio-Rad, Catalog No. 164-5050). and the gel was covered with
1 xTBE. Then, 1 yuL of Blue Gel Loading Dye (6 x ) was mixed with 5 ^L of the
DNA or RNA samples. Afterward, 6 ^L of the mixture was loaded into the well,
and 5 /j,L of 1kb DNA ladder (BioPioneer, Catalog No. MDL-1000) was loaded
into the first well as a DNA size marker. The lid was then placed back on the
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electrophoresis apparatus. The gel was run at 120 V for 30 minutes. DNA size
and RNA integrity were then examined in the gel under UV light. The gel was
photographed using a Bio-Rad Gel Doc 2000 Imaging System.
2.11 RNA REVERSE TRANSCRIPTION
RNA reverse transcription was carried out by QuantiTect® Reverse
Transcription Kit (Qiagen, Catalog No. 205310) using Bio-Rad iCycler™ Thermal
Cycler in Dr. Wayne L. Hynes’ lab. The kit was store at -2 0 °C , and the tips and
tubes were Nuclease-free. RNase-Zap was sprayed on working area to eliminate
RNase contamination. All reactions were set up on ice to minimize the risk of
RNA degradation. The procedures were referenced from the QuantiTect®
Reverse Transcription Handbook.
NRT control reaction contains all components including template RNA except
for the Quantiscript Reverse Transcriptase. Reverse transcription therefore
cannot take place, and the only template available is the contaminating genomic
or environmental DNA. If the NRT control is not amplified in the downstream
quantitative real-time PCR, it indirectly indicates that the total RNA was not
contaminated with genomic or environmental DNA, i.e., no DNA contaminant
would interfere with the downstream quantitative real-time PCR.
When set up more than one reaction, a master mix of reagents was prepared
with a volume at least 10% greater than that required for the total number of
reactions to be performed, allowing enough volume for each reaction. The extra
volume is used to compensate for the volume loss during transfers.
The extracted total RNA (template) was thawed on ice. Quantiscript® Reverse
Transcriptase, gDNA Wipeout Buffer, Quantiscript RT Buffer, RT Primer Mix, and
RNase-free water were thawed at room temperature. Each solution was mixed
by flicking the tubes. The residual liquid from the sides of the tubes was collected
by brief centrifugation and kept on ice. The genomic DNA elimination reaction
was prepared on ice (Table 2).

The amount of RNA templates for single pulse

experiments was 200 ng, whereas that for multiple pulses experiments was 100
ng. The genomic DNA elimination reaction mix was incubate for 2 minutes at
42°C, and then placed immediately on ice. RT Primer Mix was mixed with 5x
Quantiscript RT Buffer at a 1:4 ratio. The reverse transcription reaction was
prepared on ice (Table 3). The template RNA was added last. The reaction was
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Table 2. G enom ic DNA E lim ination Reaction C om ponents
Component

Volume/reaction

gDNA Wipeout Buffer, 7x

2 uL

Template RNA

Variable

RNase-free water

Variable

Total reaction volume

14 uL

Table 3. Reverse Transcription Reaction C om ponents
Component

Volume/reaction

Quantiscript Reverse Transcriptase

1 uL

Mixture of Quantiscript RT Buffer 5x and RT Primer Mix

5 uL

Template: entire genomic DNA elimination reaction

14 uL

Total reaction volume

20 uL

mixed and then stored on ice. The reaction was incubated for 15 minutes at 42°C
and immediately incubated for 3 minutes at 95°C to inactivate the Quantiscript
Reverse Transcriptase. The products of the reverse transcription reactions
(cDNAs) were stored at -2 0 °C and used as template for the quantitative
real-time PCR.
2.12 QUANTITATIVE REAL-TIME PCR
quantitative real-time PCR was carried out using iQ™ SYBR® Green
Supermix Kit (Bio-Rad, Catalog No. 170-8880) in Dr. Wayne L. Hynes’
laboratory. The kit was stored at -2 0 °C , and the tips and tubes were
nuclease-free. The working area was cleaned to eliminate RNase contamination.
The procedures were extracted from the iQ™ SYBR® Green Supermix
Instructions. MIA primers (Qiagen, Catalog No. QT01058673) and /3-actin
primers (Qiagen, Catalog No. QT00095242) were used. The MIA amplicon
length was 103 bp, whereas the /?-actin amplicon length was 149 bp.
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The no template control (NTC) reaction contains all the components of the
PCR reaction except for the cDNA template, thereby enabling the detection of
carryover contamination from previous experiments, DNA contaminant, and
primer dimer. If the NTC reaction has amplification in the quantitative real-time
PCR, it represents carryover contamination from previous experiments, a DNA
contaminant during PCR preparation, or the formation of a primer dimer.
About 1.1 mL ofTE, pH 8.0, provided by Dr. David Gauthier, was added to the
QuantiTect Primer Assay tubes. The tubes were vortexed for four to six times.
The obtained reverse transcription reaction and primers were thawed on ice. Up
to 2 (A. of template was derived directly from the obtained reverse transcription
reaction (20 ng of temple for single pulse, 10 ng of template for multiple pulses).
The iQ™ SYBR® Green Supermix was thawed to room temperature. The
Supermix was mixed thoroughly, centrifuged briefly to collect solution at the
bottom of tubes, and then stored on ice protected from light. The master mix for
all reactions was prepared by adding all required components, except for the
cDNA template (Table 4). The master mix was mixed thoroughly to ensure

Table 4. Q uantitative Real-Time PCR Reaction C om ponents
Component

Volume/reaction

Final Concentration

iQ™ SYBR® Green Supermix (2x)

10 uL

1x

10x QuantiTect Primer Assay

2 uL

1x

cDNA template

2 uL

20 ng or 10 ng

Nuclease-free water

6 uL

—

Total reaction volume

20 uL

—

homogeneity and aliquoted equally into the wells of an unskirted low-profile
48-well clear qPCR plate (Bio-Rad, Catalog No. mLL4801). The cDNA template
was added to the wells containing the master mix and the wells were sealed with
flat caps. The 48-well plate was spun at 4000 rpm for 5 minutes to remove any
air bubbles and collect the reaction mixture in the vessel bottom.

32

The thermal cycling protocol was programmed on the MiniOpticon™
Real-Time PCR Detection System (Bio-Rad, Catalog No. CFB-3120), in standard
mode (Table 5). Afterward, the PCR plate was loaded onto the MiniOpticon™
PCR instrument and the PCR run was started.

Table 5. Thermal C ycling P rotocol
Process

Temperature

Time

Polymerase Activation and DNA Denaturation

95°C

3 minutes

Denaturation

95°C

10 seconds

Annealing/Extension+Plate Read

60°C

30 seconds

Melt Curve A nalysis

Use

A m p lifica tio n (40 cycles)

default

setting

2.13 STATISTICS
Data were analyzed in a two-way fixed ANOVA using the SPSS 20.0.0
program. Transformations were calculated as follows: ’Transform’ -4 ’Compute
Variable’ with logarithmic, square root, reciprocal, and power of e. Residues were
generated by ’Analyze’ -> ’General Linear Model’ -4 ’Univariate’ -4 ’Save’ -4
check ’Unstandardized Residuals’. Normality were checked by ’Analyze’ -4
’Descriptive Statistics’ -4 ’Explore’ -4 check ’Normality plots with tests’. In the
same window, in the 'Spread vs Level WITH LEVENE Test’ box, check
’Untransformed’ for homogeneity of variance checking.
Significance (p-value) was calculated as follows: ’Analyze’ -4 ’General Linear
Model’ -4 ’Univariate’ -4 put data in the ’Dependent Variable’ box, input treatment
and time in the ’Fixed Factor(s)’ box. Interaction graph was generated by same
procedure above, ’Plots...’ -4 put treatment in the ’Separate Lines:’ box, put time
in the ’Horizontal Axis:’ box -4 click ’Add’ -> ’Continue’. Tukey follow-up test was
generated by the same procedure above, ’Post Hoc...’ -4 input time in the 'Post
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Hoc Tests for:’ box -» check ’Tukey’. Observed power was generated by the
same procedure above, ’Options’ - * check ’Observed power’ in the ’Display’ box
-> ’Continue’.
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CHAPTER 3

RESULTS

3.1 CELL ATTACHMENT ABILITY TEST AFTER A SINGLE PULSE
To test the cell attachment ability after a single 300 ns 40 kV/cm pulse, the live
and dead cells that did not attach after decanted the medium were counted in the
floating medium at 6, 12, 18, and 24 h post-pulsing. This test is based on the
inability of cells to adhere, leaving them to float in the growth medium and remain
unattached to the bottom of the well. The live and strongly attaching cells would
adhere onto the plate. The number of dead and live cells in the growth medium
indicates how many cells detached and the viability of the cells in the floating
medium of both the experimental group and the control groups.
The cells after a single 300 ns 40 kV/cm pulse were cultured for 6, 12, 18, and
24 h after pulsing. The dead and live cells in the growth media from each well of
the 24-well plate were counted on a hemocytometer using trypan blue. The
number of dead, live, total cells in the floating media, and the viability of the
floating cells were recorded (Table 6) and analyzed using the two-factor fixed
model ANOVA.
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TabSe 6. Num ber o f Floating Cells and Cell V ia b ility in th e G row th Media
Time

Trial Treatment

Live

Dead

Total

Viability

(x104

(x104

(x104

(%)

cells)

cells)

cells)

6 hours

1

One Pulse

0.2

0

0.2

100

6 hours

2

One Pulse

0

0.4

0.4

0

6 hours

3

One Pulse

0.2

0.4

0.6

33.3

6 hours

1

Control

0

0.2

0.2

0

6 hours

2

Control

0.2

0

0.2

100

6 hours

3

Control

1

0

1

100

12 hours

1

One Pulse

0.2

0.2

0.4

50

12 hours

2

One Pulse

0.6

0

0.6

100

12 hours

3

One Pulse

0

0

0

-

12 hours

1

Control

0

0

0

-

12 hours

2

Control

0.2

0.2

0.4

50

12 hours

3

Control

0.4

0.2

0.6

66.7

18 hours

1

One Pulse

0

0

0

-

18 hours

2

One Pulse

0

0

0

-

18 hours

3

One Pulse

0.2

0

0.2

0

18 hours

1

Control

0.6

0

0.6

100

18 hours

2

Control

0

0

0

-

18 hours

3

Control

0

0

0

-

24 hours

1

One Pulse

0

0

0

-

24 hours

2

One Pulse

0

0.4

0.4

0

24 hours

3

One Pulse

0

0

0

-

24 hours

1

Control

0

0

0

-

24 hours

2

Control

0.2

0.2

0.4

50

24 hours

3

Control

0

0

0

-
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S tatistic parameters: IBM® SPSS® Statistics Version 20.0.0 was used to
conduct the two-factor fixed model ANOVA. A Tukey follow-up test was carried
out for multiple comparisons and to compare the time points factors. The
independent factors include Factor A (the treatments) included two levels, a
single pulse group and a control group, and factor B (is the time points) including
four levels: 6, 12, 18, and 24 h. The dependent variables include number of live,
dead, and total cells in the growth medium in each well. The sample number and
replicates in this study are three wells per treatment per time point (n=3); two
treatments per time point, four time points per treatment; 24 wells (samples) in
total.
Statistical hypotheses (only showing live cells as an example):
H 0 : The number of live cells in the growth media does not significantly differ
between the experimental group and the control group excluding the time
points
H a : The number of live cells in the growth media significantly differs between the
experimental group and the control group excluding the time points
H '0 : The number of live cells in the growth media does not significantly differ
among the different time points excluding the treatment
H'a \ The number of live cells in the growth media significantly differs among the
different time points excluding the treatment
H'q. The treatments do not significantly interact with the time points in terms of
the number of live cells in the growth media
H"a \ The treatments significantly interact with the time points in terms of the
number of live cells in the growth media
A ssum ption checking and data tra n sfo rm a tio n s: Errors are independent
and identically distributed because the cells in each well were pulsed in individual
pulsing cuvette. Thus, treatments are applied independent of the replicates. The
cells in each well did not affect the cells in the other wells. No autocorrelation was
observed. The assumption of independent errors was met. The identically
distributed assumption will be checked in next step. The data were checked for
normality and homogeneity, and subjected to data transformation. Assumptions
checking of residuals suggests that neither the original data nor the subsequent
transformations (natural log, square root, reciprocal, exponential) sufficiently
fulfilled the assumptions. Therefore, the rank values obtained from the original
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data were analyzed.
Results based on rank data: The results of the two-way ANOVA (2x4, pure
model I) analysis indicate that the null hypotheses (H 0 , H'0 , H q) should be
accepted instead of the alternative hypothesis, i.e., the number of live, dead, and
total cells did not differ significantly among the different time points, as well as
between the two treatment groups (Table 7, 8, 9 ). No significant interaction was
observed between the time points and the treatments in terms of the number of
live, dead, and the total number of cells in the medium (Figure 9, 11, 13).
The results of this study indicate no significant interaction between the
treatments and the time points in terms of the number of live cells in the growth
media (F=0.073; df=3, 16; P=0.974) (Figure 9). The observed power in SPSS
was 0.060. The number of live cells in the growth media did not significantly differ
between the treatments (F=0.452; df=1, 16; P=0.511) (Figure 10). The observed
power in SPSS was 0.097. The number of live cells did not significantly differ
among the different time point (F=1.280; df=3,16; P=0.315). The observed power
in SPSS was 0.277.
No significant interaction was observed between the treatments and time
points in terms of the number of dead cells in the growth media (F=0.630; df=3,
16; P=0.974) (Figure 11). The observed power in SPSS was 0.153. The number
of dead cells in the growth media did not significantly differ between the
treatments (F=0.118; df=1, 16; P=0.736) (Figure 12). The observed power in
SPSS was 0.062. The number of live cells did not significantly differ among the
different time points (F=1.346; df=3,16; P=0.295). The observed power in SPSS
was 0.290.
No significant interaction were observed between the treatments and the time
points in terms of the total number of cells in the growth media (F=0.049; df=3,
16; P=0.985) (Figure 13). The observed power in SPSS was 0.057. No
significant difference was observed in the number of dead cells in the growth
media between the treatments (F=0.049; df=1, 16; P=0.828) (Figure 14). The
observed power in SPSS was 0.055. No significant difference was observed in
the number of live cells in the growth media among different time groups
(F=1.967; df=3,16; P=0.160). The observed power in SPSS was 0.412.
The observed powers in SPSS were all low, less than 0.7, thereby increasing
the risk of a type II errors (false negatives). Large sample sizes may help
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minimize this error in future studies.
All the aforementioned results suggest that a single 300 ns 40 kV/cm pulse
does not change the number of floating cells compared with the control group.
Therefore, a single 300 ns 40 kV/cm pulse does not affect cell attachment ability
within 24 h of pulsing.

Table 7. Rank o f the Num ber o f Live Cells in the G row th Media after a Single
Pulse, Two-Way Fixed ANOVA Table

r m .m .a r y ,

—■■"■“ir- . : 1 ■ ■ ■‘ -n .

Source

ikw ,,*

df

Mean

......—w — »■—

F

Significance

Square

- i—

Observed
Power

Treatment

1

37.500

0.452

0.511

0.097

Time

3

106.333

1.280

0.315

0.277

Treatment x Time

3

6.056

0.073

0.974

0.060

Error

16

83.042

Total

24

Corrected Total

23

■>
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Table 8. Rank o f the Num ber o f Dead Cells in the G row th Media a fter a
Single Pulse, Two-Way Fixed ANOVA Table
Source

df

Mean

F

Significance

Square

Observed
Power

Treatment

1

9.375

0.118

0.736

0.062

Time

3

106.931

1.346

0.295

0.290

Treatment x Times

3

50.042

0.630

0.974

0.153

Error

16

79.417

Total

24

Corrected Total

23

o
e
s
a

Table 9. Rank o f the Total Num ber o f Cells in the G row th Media after a
Single Pulse, Two-Way Fixed ANQVA Table_________________________
Source

df

Mean

F

Significance

Observed
Power

Square
Treatment

1

3.375

0.049

0.828

0.055

Time

3

136.486

1.967

0.160

0.412

Treatment x Times

3

3.375

0.049

0.985

0.057

Error

16

69.375

Total

24

Corrected Total

23
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Figure 9. interaction Plot o f the Num ber o f Live Cells between Treatm ents
and Time Points after a Single Pulse
The live cells in the growth media after a single 300 ns 40 kV/cm pulse, as well as in the unpulsed
group were counted using trypan blue after 6, 12, 18, and 24 h of culture. The live cells remain
clear. The solid line (control group) and the dashed line (one pulse group) are almost parallel.
No significant interaction was observed between the time points and the treatment in terms of the
number of live cells in the growth media (F=0.073; df=3, 16; P=0.974), n=3.
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Figure 10. Number o f Floating Live Cells a fter a Single Pulse
The floating live cells in the growth media after a single 300 ns 40 kV/cm pulse, as well as in the
unpulsed group were counted using trypan blue after 6, 12, 18, and 24 h of culture. The clear
staining cells are live cells. The number of floating live cells did not significantly differ between the
single pulse group and the control group (F=0.452; df=1, 16; P=0.511). The number of floating
live cells did not significantly differ among the 6, 12, 18, and 24 h time points (F=1.280; df=3,16;
P=0.315). The data shown are means±SEM, n=3.
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Figure 11. interaction Plot o f the Num ber o f Dead C ells between the
Treatments and the Time P oints after a S ingle Pulse
The dead cells in the growth media after a single 300 ns 40 kV/cm pulse, as well as in the unpulsed
group were counted using trypan blue after 6, 12, 18, and 24 h of culture. The dead cells were
stained blue. The solid line (control group) and the dashed line (one pulse group) are almost
parallel. No significant interaction was observed between the time points and the treatments in
terms of the number of dead cells in the growth media (F=0.630; df=3, 16; P=0.974), n=3.
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Figure 12. d u m b e r o f Fioating Dead Ceils a fter a S ingle Pulse
The number of floating dead cells in the growth media after a single 300 ns 40 kV/cm pulse, as
well as in the unpulsed group were counted using trypan blue after 6, 12, 18, and 24 h of culture.
The dead cells were stained blue. The number of dead cells did not significantly differ between the
single pulse group and the control group (F=0.118; df=1, 16; P=0.736). The number of dead cells
in the growth media did not significantly differ among the 6, 12, 18, and 24 h time points (F=1.346;
df=3,16; P=0.295). The data shown are means±SEM, n=3.
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Figure 13. Interaction Plot o f the Num ber o f Dead Cells between the
Treatment and the Time P oints after a S ingle Pulse
The total number of cells in the growth media after a single 300 ns 40 kV/cm pulse, as well as in
the unpulsed group were counted using trypan blue after 6, 12, 18, and 24 h of culture. The total
number of cells was equal to the number of live cells plus the number o f dead cells. The solid line
(control group) and the dashed line (one pulse group) are almost parallel. No significant interaction
was observed between the time points and the treatment in terms of the total number of cells in the
growth media (F=0.049; df=3, 16; P=0.985), n=3.
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Figure 14, Total Num ber off the Floating Cells after a S ingle Pulse
The floating live and dead cells in the growth media after a single 300 ns 40 kV/cm pulse, as well
as in the unpulsed group were counted using trypan blue after 6, 12, 18, and 24 h of culture. The
total number of cells was equal to the number of live cell plus the number of dead cells. The total
number of cells in the growth media did not significantly differ between the single pulse group and
the control group (F=0.049; d f= 1 ,16; P=0.828). The total number o f cells did not significantly differ
among the 6, 12, 18, and 24 h time points (F=1.967; df=3,16; P=0.160). The data shown are
means±SEM, n=3.
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3.2 CELL MORPHOLOGY AFTER A SINGLE PULSE
To examine the changes in cell morphology after a single 300 ns 40 kV/cm
pulse, single pulsed cells and unpulsed cells (control) were seeded immediately
after pulsing and cultured in the incubator. The cells were observed and
photographed under a Nikon inverted microscope at 200 x magnification at 6, 12,
18, and 24 h after pulsing (Figure 15).
Cell shape was defined as the contour or outline of the cell attaching area on
the 24-well plate surface, which is determined by the cell adhesion ability. Larger
attachment areas indicate stronger adhesion ability. The shape of the attachment
area changed with time. The cells that have just attached onto the 24-well plate
surface were round. The cells then spread out on two ends, forming a spindle
shape. The cell contents then move from one end to the other end, forming an
umbrella shape. The cells then grow spines and form polygonal shapes.
However, the biological procedure during these shape changes is still unclear.
Thus, analyzing these changes in shape provides an opportunity to examine the
changes in attachment ability.
Almost all the cells from both control and single pulse groups adhered to the
24-well plate surface at 6 h (Figure 15A, 15B). Most of the cells were
spindle-shaped, with one end spreading out like umbrella. At 12 h, some cells
rounded up to divide due to weak adhesion (Figure 15C, 15D). Some cells
spread out further and became polygonal or stelate at 18 h (Figure 15E, 15F). At
24 h, Some cells spread out even further (Figure 15G, 15H). Some cells produce
dendrite-like or axon-shape spines, overlapping each other at 18 and 24 h. No
obvious difference in cell shape and spreading area were observed between the
control group and the single pulse group under direct visualization.
All the results above show that the single pulse group and the control group
cells did not significantly differ in cell shape and spread area at 6, 12, 18, and 24
h after 300 ns 40 kV/cm pulsing. Thus, a single 300 ns 40 kV/cm pulse does not
change the attach ability, which supports the previous floating cell number test.
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Figure 15. Cell Morphology after a Single Pulse
(A, C, E, G) Cells were seeded and cultured without pulsing at 6, 12, 18, and 24 h, respectively.
(B, D, F, H) Cells were seeded and cultured until 6, 12, 18, and 24 h after a single 300 ns 40 kV/cm
pulse, respectively. Scale bar=100 /xm.
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Two methods can be used to examine the difference in the number of cells
that attached onto the 24-well surface between the pulsed and unpulsed cells.
One is to harvest the cells using EDTA-trypsin treatment, and then counting the
cell number using a hemocytometer. The other way is to estimate the number of
attached cells in terms of the cell density in micrographs.
Considering the number of floating cells did not significant differ between the
single pulse group and control group at 6, 12, 18, and 24 h and that the number
of cells in the cuvettes in the single pulse group were the same as those in the
control group, the number of attached cells should have no significant
differences. Thus, the cell densities in micrographs were used to estimate the
number of attached cells under direct visualization. However, for later multiple
pulses, the attached cells were harvested using EDTA-trypsin and counted using
a hemocytometer.
The cell density examination averages the cell density in at least two sets of
photographs to cancel out the random error. Thus, another set of photographs
are shown. The cell densities of the single pulse group seemed less in one set of
photographs (Figure 15), but seemed more in the other set of photographs (
Figure 16). The average cell density in the two photographs did not significantly
differ between the single pulse group and control group at 6, 12, 18, and 24 h.
These results indicates that single pulse does not change the number of attached
cells, which is consistent with the finding that single pulse does not change the
attachment ability in the floating cell assay.
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Figure 16. A Second Set o f Cell M o rp ho lo g y P hotographs
(A, C, E, G) Cells were seeded and cultured without pulsing at 6, 12, 18, and 24 h, respectively.
(B, D, F, H) Cells were seeded and cultured until 6, 12, 18, and 24 h after a single 300 ns 40 kV/cm
pulse, respectively. Scale bar=100 fim.)
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3.3 LONG-TERM VIABILITY TEST AFTER MULTIPLE PULSES
3.3.1 TOTAL CELL VIABILITY TEST AFTER MULTIPLE PULSES
The number of attached and floating cells in each well were counted at 6, 12,
18, and 24 h after pulsing and incubation using the trypan blue viability test to
determine the long-term cell viability and cell growth ability after multiple 300 ns,
40 kV/cm pulses. The total number of live cells is the sum of the number of
attached live cells and the number of floating live cells. The total number of dead
cells is the sum of the number of attached dead cells and the number of floating
dead cells. The viability values were then calculated (Equation 2).
The nature log, square root, reciprocal, and exponential transformation did not
meet the assumptions for normal distribution and homogeneity of variance.
Therefore, the rank values of the raw viability values were used in the two-way
fixed ANOVA. The hypotheses were similar to those previously described for the
single 300 ns 40 kV/cm pulse treatment, except for the four levels (control group
and two-, three-, and four-pulse groups) in the treatment factor. Three replicates
were conducted.
The result of the two-way fixed ANOVA indicates that cell viability did not
significantly differ among the 6, 12, 18, and 24 h time points (F=1.434; df=3, 32;
P=0.251) (Table 10), but significantly differed among the different number of
pulses (F=2516.799; df=3, 32; P<0.0000005). No significant interaction was
observed between the time points and the pulse treatments (F=22.113; df=9, 32;
P=0.810) (Figure 17). The Tukey’s follow-up test shows that the cell viability of
the control group differed significantly from the two-, three-, and four-pulse
groups (all P 0 .0 0 0 1 ) (Figure 18). The cell viability of the two-pulse group was
significantly different from those of three- pulse group and four-pulse group (all
P<0.0001). However, that of the three-pulse gout did not significantly differ from
that of the four-pulse group.
Therefor, multiple 300 ns 40 kV/cm pulses significantly decrease total cell
viability compared with that of the control group. The total cell viability after three
or four pulses was significantly lower than that after two pulses. These results
indicate that total cell viability decreases with the number of pulses. This finding
provides a good opportunity to reduce the melanoma of melanoma cells in clinical
treatment.
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Table 10. Rank of Long-term Total Cell Viability (%) after Multiple Pulses,
Two-Way Fixed ANOVA Table________________________________________
Source

df

Mean

F

Significance

Square
Time

3

55.465

Pulses

3

Timex Pulses

9

22.113

Error

32

38.688

Total

48

Corrected Total

47

2516.799

Observed
Power

1.434

0.251

0.343

65.055

<0.0000005

1.000

0.572

0.810

0.228
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Figure 17. Long-term Total Cell Viability interaction Graph after Multiple
Pulses
The attached and floating cells after two, three, and four 300 ns 40 kV/cm pulses, as well as in
the unpulsed group were counted using trypan blue after 6, 12, 18, and 24 h of culture. The total
number of live cells is equal to the number of attached live cells plus the number of floating live
cells. The total number of dead cells is equal to the number of attached dead cells plus the number
of floating dead cells. Total cell viability was counted (Equation 2). The solid line (control group)
and the three dashed lines (two-, three-, and four-pulse groups) were almost parallel. No significant
interaction was observed between the time points and the pulse treatments in terms of total cell
viability (F=22.113; df=9, 32; P=0.810), n=3.
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Figure 13. Long-term Total Cell Viability after Multiple Pulses
The attached and floating cells after two, three, and four 300 ns 40 kV/cm pulses, as well as in
the unpulsed group were counted using trypan bus after 6, 12, 18, and 24 h of culture. The total
number of live cells was equal to the number of attached live cells plus the number of floating live
cells. The total number of dead cells was equal to the number of attached dead cells plus the
number of floating dead cells. The total cell viability was counted (Equation 2). Total cell viability
significantly differed among the different pulse treatments (F=2516.799; df=3, 32; P<0.0000005).
The Tukey’s follow-up test shows that the cell viability of the control group was significantly higher
than those in the two-, three-, and four-pulse groups (all P<0.0001). The cell viability of two-pulse
group was significantly higher than those of the three- and four-pulse groups (all P<0.0001), but it
did not significantly differ between the three-pulse group and the four-pulse group. The data shown
are the means±SEM, n=3.
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3.3.2 TOTAL LIVE CELL NUMBER AFTER MULTIPLE PULSES
The attached and floating live cell were counted using a trypan blue test at 6,
12, 18, and 24 h after pulsing and incubation to determine how many live cells
were left and the differences in cell growth among the multiple pulse treatments.
The total number of live cells was equal to the number of attached live cells plus
the number of floating live cells.
The natural log, square root, reciprocal, and exponential transformation did
not exhibit a normal distribution and was non-homogenous. Therefore, the rank
values of the total number of live cells were used to conduct two-way ANOVA.
The hypotheses were similar to those previously described for the single pulse
treatment, except for the four levels (control group and two-, three-, and
four-pulse groups) in the treatment factor. Three replicates were conducted.
The two-way fixed ANOVA indicates that the total number of live cells
significantly differed among the 6, 12, 18, 24 h time points (F=221.861; df=3, 32;
P=0,021) ( Table 11). The total number of live cells significantly differed among
the multiple pulse treatments (F=2301.806; df=3, 32; P<0.0000005). No
significant interaction was observed between the time points and the multiple
pulse treatments (F=30.028; df=9, 32; P=0.862) (Figure 19). The Tukey’s
follow-up test of the time points showed significant differences in the total number
of live cells between the 12 h and the 18 h time points (P=0.011) (Figure 20). The
Tukey’s follow-up test of the multiple pulse treatments showed that the total
number of live cells in the control group significantly differed from those of the
two-, three-, and four-pulse treatments (all P<0.0001). The total number of live
cells in the two-pulse group was significantly different from those in the three- and
four-pulse groups (P=0.013 and 0.000182, respectively).
The aforementioned results indicate that two, three, and four 300 ns 40 kV/cm
pulses significantly decreased the total number of live cells compare with the
control group. Increasing the number of pulses also increased cell death. These
results are very promising for reducing melanoma size and cell number in future
melanoma treatments.

55

Table 11. Rank of Total Number of Live Cells after Multiple Pulses, Two-Way
Fixed ANOVA Table____________________________________________________
Source
df
Mean
F
Significance
Observed
Square
Time

3

221.861

Pulses

3

Timex Pulses

9

30.028

Error

32

59.771

Total

48

Corrected Total

47

2301.806

Power
3.712
38.511
0.502

0.021
<0.0000005
0.862

0.754
1.000
0.202
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Figure 19. Long-Term Total Number of Live Cells after Multiple Pulses
The attached and floating cells after two, three, and four 300 ns 40 kV/cm pulses, as well as in
the unpulsed group were counted using trypan blue after 6, 12, 18, and 24 h of culture. The total
number of live cells was equal to the number of attached live cells plus the number of floating live
cells. The solid line (control group) and the three dashed lines (two-, three-, and four-pulse groups)
were almost parallel. No significant interaction was observed between the time points and the
multiple pulse treatments in terms of the total number of live cells (F=30.028; df=9, 32; P=0.862),
n=3.
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Figure 20. Long-Term Total Num ber o f Live Cells after M ultiple Pulses
The attached and floating cells after two, three, and four 300 ns 40 kV/cm pulses, as well as in
the unpulsed group were counted using trypan bus after 6, 12, 18, and 24 h of culture. The total
number of live cells was equal to the number of attached live cells plus the number of floating live
cells. The total number of live cells significantly differed among the 6, 12, 18, and 24 h time points
(F=221.861; df=3, 32; P=0,021). The Tukey’s follow-up test of the time points showed a significant
difference in the total number of live cells between the 12 h and the 18 h time points (P=0.011). The
total number of live cells significantly differed among the multiple pulse treatments (F=2301.806;
df=3, 32; P<0.0000005). The Tukey’s follow-up test of the multiple pulse treatments showed that
the total number of live cells in the control group was significantly higher than those in the two-,
three-, and four-pulse treatments (all P<0.0001). The total number of live cells in the two-pulse
group was significantly higher than those in the three-pulse group (P=0.013) and four-pulse group
(P=0.000182). The data shown were means±SEM, n=3.
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3.3.3 TOTAL NUMBER OF DEAD CELLS AFTER MULTIPLE PULSES
The total number of dead cells were counted using trypan blue at 6, 12, 18,
and 24 h after pulsing and incubation. The total number of deal cells was equal to
the number of attached dead cell plus the number of floating dead cells.
The natural log plus 1 transformation best exhibited a normal distribution and
homogeneity. Therefore, the natural log transformation was used to conduct a
two-way fixed ANOVA. The hypotheses were similar to those previously
described for the total number of live cells. Three replicates were conducted.
The two-way fixed ANOVA indicated no significant interaction between the
time points and the multiple pulse treatments (F=0.809; df=9, 32; P=0.611)
(Table 12, graph not shown). The total number of dead cells significantly differed
among the 6, 12, 18, and 24 h time points (F=3.499; df=3, 32; P=0.027)
(Figure 21). The total number of dead cells significantly differed among the two-,
three-, and four-pulse groups and the control group (F=124.378; df=3, 32;
P<0.0000005). The Tukey’s follow-up test of the time points comparisons
revealed that the total number of dead cells at 12 h was significantly different
from that at 24 h (P=0.021). The Tukey’s follow-up test of the pulse treatment
comparisons show that the total number of dead cells in the control group was
significantly different from those in the two-, three-, and four-pulse groups (all
P<0.0000005).
These results indicate that multiple pulses cause significant cell death, which
is consistent with the decrease in total cell viability and in the number of total live
cells.
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Table 12. Natural Log Transformation of the Total Number of Dead Cells
after Multiple Pulses, Two-Way Fixed ANOVA Table
Source

df

Mean

F

Significance

Square

Observed
Power

Time

3

0.218

3.499

Pulses

3

7.746

124.378

Timex Pulses

9

0.050

Error

32

0.062

Total

48

Corrected Total

47

0.809

0.027
<0.0000005
0.611

0.726
1.000
0.323
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Figure 21. Long-Term Total Number of Dead Cells after Multiple Pulses
The attached and floating cells after two, three, and four 300 ns 40 kV/cm pulses, as well as in
the unpulsed group, were counted using trypan bus after 6, 12, 18, and 24 h of culturing. The
total number of dead cells was equal to the number of attached dead cells plus the number of
floating dead cells. No significant interaction was observed between the time points and the multiple
pulse treatments (F=0.809; df=9, 32; P=0.611). The total number of dead cells significantly differed
among the 6, 12, 18, and 24 h time points (F=3.499; df=3, 32; P=0.027). The Tukey’s follow-up
test of time point comparisons showed that the total number of dead cells at 12 h was significantly
higher than that at 24 h (P=0.021). The total number of dead cells significantly differed among
the two-, three-, and four-pulse groups and control group (F=124.378; df=3, 32; P<0.0000005).
The Tukey’s follow-up test of the pulse treatment comparisons showed that the total number of
dead cells in the control group was significantly lower than those in the two-, three-, and four-pulse
groups (all P<0.0000005). The data shown were means±SEM, n=3.
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3.4 CELL ATTACH ABILITY AFTER MULTIPLE PULSES
The attached and floating cells were counted using trypan blue to determine
the changes in cell attachment ability at 6, 12, 18, and 24 h after multiple 300 ns
40 kV/cm pulses. The cell attachment ability can be represented in two ways.
One way is as the percentage of the attached live cellos of the total number of
live cells. The total number of live cells is equal to the number of attached live
cells plus the number of floating live cells. The other way is by comparing the
number of live, dead, and the total cells in the floating growth medium with those
of the attached live, dead, and total cells attached to the plate surface.
Interpreting the comparison between the number of floating cells and number of
attached cells is difficult and complex because multiple pulses cause cell death.
Therefore, we only tested the cell attach ability using the percentage of attached
live cells among the total live cells.
The attached and floating cells were counted at 6, 12, 18, and 24 h after two,
three, and four 300 ns 40 kV/cm pulses and incubation. Cell attachment ability is
represented as the percentage of the attached live cells among the total live cells.
Three replicates were conducted.
The data transformed using natural log, square root, reciprocal, and
exponential transformation did not meet the assumptions for normal distribution
and homogeneity of variance. Thus, the rank values of the percentage of
attached live cells were used to conduct a two-way fixed ANOVA. The hypotheses
were similar to those for single pulse attachment ability, except for the four levels
of the treatment factor (control group and two-, three-, and four-pulse groups).
The two-way fixed ANOVA indicated no significant interaction between the
time points and the pulse treatments (F=2.037; df=3, 32; P=0.067) (Table 13,
graph not shown). The percentage of attached cells significantly differed among
the 6, 12, 18, and 24 h time points (F=6.353; df=3, 32; P=0.002). The percentage
of attached cells significantly differed among the two-, three-, and four-pulse
groups and the control group (F=10.724; df=3, 32; P<0.00005) (Figure 22). The
Tukey’s follow-up test of the time point comparisons revealed that the percentage
of attached cells at 24 h was significantly different from those at 6, 12, and 18 h
(all P<0.05). The Tukey’s follow-up test of the pulse treatments show that the
percentage of attached cells in the control group was significantly different from
those in the two-pulse group (P=0.014), the three-pulse group (P=0.004), and the
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four-pulse group (P=0.00002).
These results indicate that two, three, and four 300 ns 40 kV/cm pulses
significantly decrease the cell attach ability, with more pulses decreasing the cell
attachment ability further.

Table 13. Rank o f the Percentage o f A ttached Cells a fte r M ultiple Pulses,
Two-Way Fixed ANOVA Table
Source

df

Mean

F

Significance

Observed
Power

Square
Time

3

586.694

6.353

0.002

0.946

Pulses

3

990.361

10.724

<0.00005

0.997

Timex Pulses

9

188.083

2.037

0.067

0.755

Error

32

92.354

Total

48

Corrected Total

47
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Figure 22. Percentage of Attached Cells after Multiple Pulses
The floating and attached live cells after two, three, four 300 ns 40 kV/cm pulses, as well as in the
unpulsed group were counted using trypan blue after 6, 12, 18, and 24 h of pushing and incuba
tion. The total number of live cells was equal to the number of floating live cells plus the number of
attached live cells. Attachment ability was the percentage of attached live cell divided by the total
number of live cells. No significant interaction was observed between the time points and the pulse
treatments (F=2.037; df=3, 32; P=0.067). The percentage of attached cells significantly differed
among the 6, 12, 18, and 24 h time points (F=6.353; df=3, 32; P=0.002). The Tukey's follow-up
test of time point comparisons show that the percentage of attached cells at 24 h was significantly
higher than those at 6,12, and 18 h time points (all P<0.05). The percentage of attached cells sig
nificantly differed among the two-, three-, and four-pulse groups and the control group (F=10.724;
df=3, 32; P<0.00005). The Tukey's follow-up test of the pulse treatments showed that the per
centage of attached cells in the control group was significantly higher than those in the two-pulse
group (P=0.014), the three-pulse group (P=0.004), and the four-pulse group (P=0.00002). The
data shown were means±SEM, n=3.
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3.5 CELL MORPHOLOGY AFTER MULTIPLE PULSES
The pulsed cells and the unpulsed cells (control) were immediately seeded
after pulsing and were cultured in an incubator to determine the changes in cell
morphology after multiple 300 ns 40 kV/cm pulses. The cells were observed and
photographed using an inverted microscope at 200x magnification at 6, 12, 18,
and 24 h after pulsing. Cell shape was described in the section on cell
morphology after a single pulse.
At 6 h after pulsing, the number of attached cells and the spread area in the
two-, three-, and four-pulse groups were significantly lower than in the control
group (Figure 23). The cells were less spread out with more pulses. The cells
subjected to four pulses exhibited the least spread area.
At 12 h after pulsing, the nuclei of the cells in the control group started to
divide (Figure 24). Some control group cells rounded up to divide, which is
caused by weak attachment of the cells onto the culturing plate. The cells after
two, three, and four pulses spread out and showed less nuclear division.
At 18 h after pulsing, the control group reached 90% confluence (Figure 25).
The cells in the control group had long spines and became multipolar or stellate.
The function of the long spines is unknown but could be traces after cell division
or traces after cell migration. The cells in all multiple pulse groups spread out.
The cells in the two-, three-, and four-pulse groups exhibited less nuclear division
and cell division than those in the control group.
At 24 h after pulsing, the nuclei of the cells in the control group were dividing
and some cells rounded up for division (Figure 26). Some of the cell nuclei
divided after two pulses to three pulses and formed long spines. Spines also
formed after four pulses, but fewer cells exhibited nuclear division and cell
division.
Therefore, multiple 300 ns 40 kV/cm pulses significantly decrease the cell
attachment area, nuclear division, and cell proliferation and slow down cell
attachment compared with the control group.
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A

B

D

Figure 23. Cell Morphology at 6 h after Multiple Pulses
(A) Unpulsed control cells.
(B) Cells after two 300 ns 40 kV/cm pulses.
(C) Cells after three pulses.
(D) Cells after four pulses. Scale bar=100

Cells were less spread out after multiple pulses.

The cells after four pulses were the least spread out among the pulse treatments.
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Figure 24. Cell Morphology at 12 h after Multiple Pulses
(A) Unpulsed control group.
(B) Two 300 ns 40 kV/cm pulse group.
(C) Three-pulse group.
(D) Four-pulse group. Scale bar=100 um. The nuclei of the control group began to divide. Some
control group cells rounded up. The cells were spread out and exhibited less nuclear division after
multiple pulses.
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Figure 25. Cell Morphology at 18 h after Multiple Pulses
(A) Unpulsed control group.
(B) Two 300 ns 40 kV/cm pulse group.
(C) Three-pulse group.
(D) Four-pulse group. Scale bar=100 /mi. The control group reached 90% confluence. The cells
in the control group formed long spines and were multipolar or stellate. The cells after two, three,
and four pulses were spread out and they exhibited less nuclear division and cell division.

68

A

B
/

c '

'j

•

/

}
"

' o

/
0

C

,.r 1 /y

:
'

((.

0

/. /
i

-

'

'

c
\

/

*

,

Ss

L

'

o
'

A
N

'

*
\

/'

'

’
'

0

_, '

.

"

e

(

j

'( (

a

f

'

C

D

/

Figure 26. Cell Morphology at 24 h after Multiple Pulses
(A) Unpulsed control group.
(B) Two 300 ns 40 kV/cm pulse group.
(C) Three-pulse group.
(D) Four-pulse group. Scale bar=100 /zm. The control group began to divide again. Long spines
were shown in the control group and multiple pulses group. Some o f the cells exhibited nuclear
division after two pulses to three pulses. No obvious nuclear division occurred in the cells after four
pulses.
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3.® RNA QUALITY CONTROL AND REAL-TIME PGR QUALITY CONTROL
The integrity and purity of the total RNA extracted from all cell samples were
tested to maintain the quality of the total RNA.
3.6.1 TOTAL RNA INTEGRITY
Gel electrophoresis was used to test total RNA integrity. Mouse 28S rRNA
was 4700 nt and 18S rRNA was 1900 nt. The theoretical 28S:18S ratio was
2.7:1. The clear 28S and 18S rRNA bands indicated the RNA was intact. A
random RNA sample was subjected to gel electrophoresis. The 28S and 18S
rRNA bands were clearly shown in lane 2 (Figure 27). The ladder is a DNA
marker, which has double strands of nucleotides. rRNA is a single strand
nucleotide. Therefore, the 4700 nt single strand of 28S rRNA was slightly smaller
than the 3000 bp DNA ladder. The 1900 nt single strand of 18S rRNA was slightly
smaller than the 1000 bp DNA ladder. The intensity of the 28S band and 18S
band was more than 2:1. The two rRNA bands were sharp. Therefore, the total
RNA samples extracted from the cell samples were intact.
3.6.2 TOTAL RNA PURITY AND CONCENTRATIONS
We took the data from the single pulse treatment as an example. The data
after the multiple pulses were similar (data not shown). The volume of the RNA
extracted from each sample was 30

}jL .

One microliter of the extracted total RNA

was analyzed for purity and concentration. The A26o/A28o ratio of all extracted
total RNA were between 1.8 and 2.1 (Table 14), which indicates that all extracted
total RNA can be considered pure RNA. The concentration of all the RNA
samples were measured and recorded.
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Figure 27. Gel Image of the RNA Sample and quantitative Real-time PCR
product
The gel electrophoresis of total RNA sample extracted from a randomLy chosen specimen and the
quantitative real-time PCR product were conducted using 1% natural agarose gel at 120 V for 30
min.
(Lane 1) DNA ladder.
(Lane 2) The extracted total RNA sample was randomLy chosen. A 28 S rRNA band (4700 nt) was
observed at around 3000 bp and a 18S rRNA band (1900 nt) was observed at around 1000 bp.
The intensity of the 28S/18S band exceeded 2:1. Therefore, the extracted total RNA sample was
intact.
(Lane 4) The intense ,0-actin band of quantitative real-time PCR product (149 bp).
(Lane 5) Very faint band of MIA quantitative real-time PCR product (103 bp).
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Figure 28. A djusted Gel Image to S how MIA Band
This is an adjusted gel image from the original gel image in Figure 27. The arrow pointing to a very
faint band in Lane 5 is MIA quantitative real-time PCR product. The MIA quantitative real-time PCR
product was 103 bp.
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Table 14. Purity and C oncentrations o f the Extracted Total RNA
Time

Trial

Treatment

A260

A280

A260

RNA con

/A280

centration
(ng/uL)

6 hours

1

Experiment

0.657

0.341

1.93

26.3

6 hours

2

Experiment

1.206

0.607

1.99

48.3

6 hours

3

Experiment

0.944

0.463

2.04

37.7

6 hours

1

Control

1.899

0.975

1.95

76.0

6 hours

2

Control

1.884

1.049

1.80

75.4

6 hours

3

Control

1.542

0.795

1.94

61.7

12 hours

1

Experiment

1.704

0.870

1.96

68.2

12 hours

2

Experiment

2.262

1.223

1.85

90.5

12 hours

3

Experiment

1.461

0.736

1.98

58.4

12 hours

1

Control

0.554

0.306

1.81

22.2

12 hours

2

Control

1.966

1.013

1.94

78.6

12 hours

3

Control

1.503

0.779

1.93

60.1

18 hours

1

Experiment

1.926

0.968

1.99

77.0

18 hours

2

Experiment

2.278

1.149

1.98

91.1

18 hours

3

Experiment

2.032

1.016

2.00

81.3

18 hours

1

Control

2.089

1.047

2.00

83.6

18 hours

2

Control

2.510

1.250

2.01

100.4

18 hours

3

Control

2.806

1.391

2.02

112.2

24 hours

1

Experiment

3.507

1.723

2.04

140.3

24 hours

2

Experiment

2.171

1.070

2.03

86.8

24 hours

3

Experiment

2.476

1.220

2.03

99.0

24 hours

1

Control

4.058

1.989

2.04

162.3

24 hours

2

Control

3.855

1.895

2.03

154.2

24 hours

3

Control

2.919

1.439

2.03

116.8
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3.6.3 REAL-TIME PCR QUALITY CONTROL
The NRT and NTC negative controls, melting curve analysis, and gel
electrophoresis of the quantitative real-time PCR product were used to control
the real-time PCR quality.
NRT and NTC negative controls
A no reverse transcriptase (NRT) negative control and a no template control
(NTC) were used during reverse transcription to check for DNA contamination of
the RNA sample. The NRT negative control and the NTC should not have any
real-time PCR product. If the NRT negative control formed a PCR product, the
total RNA sample was contaminated with genomic or environmental DNA.
The Taq DNA polymerase used in the real-time PCR acts as a reverse
transcriptase(Martel et al., 2002), which generates cDNA from RNA during the
real-time PCR step. The RNA sample was treated with 1 fiL of 1 mg/mL RNase A
(Bioo Scientific, Catalog No. 344005) at 37°C for 30 min in the cell culture
incubator before conducing a reverse transcription reaction to eliminate false
positive NRT results.
The quantification cycle (Cq) value is the number of cycles required for the
fluorescent signal to exceed the threshold. The Cq value is inversely proportional
to the amount of target nucleic acid in the sample. The Cq value of the NRT
negative control was between 38 cycles to 40 cycles (Figure 29), which indicates
the occurrence of a very weak reaction and minimal amounts of the target nucleic
acid, genomic, or environmental contamination. The Cq of the NRT negative
control was 8 cycles more than the MIA amplified samples, which means that the
DNA contamination in the RNA samples is less than 0.5% of the cDNA.
Therefore, the RNA and cDNA samples were not significantly contaminated with
DNA.
DNA-free/RNA-free water was used to replace the cDNA template during the
real-time PCR procedure, which is called the NTC, to test for non-specific PCR
products and DNA contamination. If the NTC negative control forms a PCR
product, non-specific PCR or DNA contamination occurred during the real-time
PCR.
The Cq value of one NTC ranged from 38 cycles to 40 cycles (Figure 29). The
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Figure 29. The NRT Negative Control and the NTC Negative Control
The Cq of the batch ^ -a c tin quantitative real-time PCR ranged from 14 cycles to 18 cycles. The
Cq of the batch MIA reactions ranged from 29 cycles to 33 cycles. The Cq values of the two NRT
negative control reactions ranged from 38 and 40 cycles. The Cq value of one NTC ranged from
38 cycles to 40 cycles. The Cq of another NTC was undetectable, which exceeded 40 cycles. The
extracted total RNA sample and the quantitative real-time PCR product were free of genomic DNA
contamination and environmental DNA contamination.

Cq of the other NTC was undetectable, which exceeded 40 cycles. These finding
indicate minimum environmental DNA contamination, which is negligible. No
PCR product was detected in the second NTC control, which indicates the
absence of non-specific products or DNA contamination.
Thus, the extracted total RNA sample and the quantitative real-time PCR
product were pure.
Melting curve analysis
A melting curve analysis was conducted to determine the presence of single
real-time PCR amplification or multiple PCR amplifications. Melting curve
analyses measures the dissociation characteristics of double-stranded DNA
during heating.
The double-standed DNA dissociates with increasing temperature, causing
decrease in absorbance. When the temperature was increased uniformLy, the
pure double-standed DNA PCR product would dissociate into single-stranded
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DNA. The resulting sharp decrease in fluorescence is caused by the dissociation
of SYBR Green to exhibit a single melting peak. Different double-standed DNA
PCR product would exhibit multiple melting peaks.
The melting peak analysis of MIA and /?-actin real-time PCR product was
performed at the end of PCR. The MIA melting peaks of all samples were
aggregated at 83°C and the /3-actin melting peaks of all samples were
aggregated at 89°C (Figure 30). The four off-peak curves are from NTC and NRT
negative control.
Thus, a single double-standed DNA PCR product was observed for MIA and
for /?-actin.

M elt Peak
0.025

$-actin 89°C
0.020

0.015

0.010

0.005

0.000
85

90

Tem perature, Celsius

Figure 30. Melting Curve Analysis
Melting curve analysis was performed at the end of quantitative real-time PCR retains. The MIA
melting peaks of all the samples were aggregated at 83°C and the /?-actin melting peaks of all the
samples were aggregated at 89°C. The four off-peak curves were obtained from the NTC and NRT
negative control.
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Gel electrophoresis of the PCR product
The size of the real-time PCR product was examined through gel
electrophoresis to test the specificity of the real-time PCR reaction. The MIA
amplicon should be 104 bp, whereas the /?-actin amplicon should be 149 bp. A
clear /?-actin band was observed below 250 bp (Figure 27), and a very faint MIA
band was found below and to the right of the ( i—actin band in the gel image
(Figure 28). These band sizes match their corresponding theoretical specific
PCR amplicon size. Therefore, the real-time PCR reactions have highly specific
amplifications.
The intensity of the 3 kb and the 1 kb bands in the ladder indicates that the
amount of the DNA was 92 ng. The intensity of the 250 bp ladder indicates that
the amount of DNA was 45 ng. Therefore, the amount of the /3-actin amplicon
was less than 92 ng and that of the MIA amplicon was much less than 45 ng. The
amounts of these PCR products are consistent with their Cq values, which shows
that /?—actin is expressed much more than MIA.
3.7 DETERMINING REAL-TIME PCR AMPLIFICATION EFFICIENCY
The amplification efficiencies of the real-time PCR were calculated via single
real-time PCR (Ramakers et al., 2003) using LinRegPCR (2012.0), a Windows
program for analyzing real-time PCR (Ruijter et al., 2009). The efficiencies were
compared with those using qpcR, an R package for real-time PCR analysis (Ritz
and Spiess, 2008).
The amplification efficiencies from all the real-time PCR reactions from the
single 300 ns 40 kV/cm pulse experiments were calculated using LinRegPCR
and qpcR, from the raw fluorescence data. The means of the amplification
efficiencies of /3-actin and MIA in both programs should be close to 2 to use the
2

—Acq method; otherwise, individual efficiency must be employed in the

calculation (Equation 3).
3.7.1 LinRegPCR:
The amplification efficiency of each real-time PCR was derived from the slope
of the regression line in the log-linear phase (Figure 31). The percentage
efficiency is shown in box plot (Figure 32). The amplification efficiency of the
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Figure 31. Determination of Individual Amplification Efficiency Using
LinRegPCR
PCR efficiency was calculated using LinRegPCR from the slope of the regression line in the loglinear phase (5 red dots). The PCR efficiency of sample 16 was 2.064, as shown in the graph.

/?-actin reactions was 2.21 ±0.27 (mean±SD, n=71), and the efficiency of the
MIA reactions was 2.04±0.15 (mean±SD, n=67). The amplification efficiencies
for both primers were close to 2. Therefore, 2 can be substituted for the
amplification efficiency. The MIA and /3-actin mRNA expression were calculated
(Equation 3).
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Figure 32. Box Plot of Amplification Efficiencies, Determined by LinRegPCR
The quantitative real-time PCR amplification efficiencies obtained using LinRegPCR were plotted.
The bottom and top of the box are the 1st and 3rd quartiles (Q1 and Q3). The band inside the box
is the 2nd quartile (Q2) or the median. The interquartile range (IQR) is Q3-Q1. The top end of the
whisker is Q1-1.5xlQR. The bottom end o f the whisker is Q 3+1.5xlQ R . The data points beyond
the whiskers are outliers. Sample 14, 17, and 38 were outliers of the /3-actin PCR efficiencies.
THe /3-actin and MIA PCR efficiencies were around 2, and were not significantly different.
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3.7.2 qpcR:
Both the /3-actin and MIA individual amplification efficiencies were analyzed
using the qpcR package of the R program. The qpcR package of the R program
was installed and loaded before typing in the following steps (the /?—actin
reaction efficiencies are shown as an example), which were modified from
Package ’qpcR’ Document as follows:
# import fluorescence raw data of all actin reactions to

'per'

> pcr=read.csv(file="Efficiency_actin.c s v " , header=TRUE)

# fit all reactions into b7 model, the best fit model
> mLl=modlist(pcr, model=b7)

# calculated efficiencies of each reaction and put into

'res'

> res=sapply(mLl, function(x) efficiency(x)$eff)

# draw a bar plot to show all actin reaction efficiencies
> barplot(as.numeric(res), xlab="beta-actin Real-time PCR
Reactions", ylab="Real-time PCR Amplification Efficiencies")

# calculate the mean efficiencies of all reactions
> mean(as.numeric(res))

# calculate the standard deviation
> sd(as.numeric(res))

The efficiencies are derived from the peak of the second derivative curve
(type=”cpD2” by default, Figure 33). The bar plots for (3—actin and MIA indicate
that the PCR efficiency of /3-actin were more than 2, whereas that for MIA was
around 2 (Figure 34 and 35). The mean amplification efficiency of (3—actin was
3.32±1.01 (mean±SD). The mean amplification efficiency of MIA was 2.19±0.11
(mean±SD). The /3-actin and MIA amplification efficiencies were close to 2.
Therefore, the PCR efficiencies of both ^ -a c tin and MIA was confirmed as 2.
The /3-actin and MIA PCR efficiencies in both LinRegPCR and qpcR were
around 2 or more than 2. The /3-actin PCR efficiency was slightly higher than the
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MIA PCR efficiency, possibly because the amount of /?-actin in the samples was
much greater than that of MIA and the Cq values of MIA was more than 10 cycles
greater than that of /3-actin. Therefore, the real-time PCR of MIA was less
efficienct after 10 more cycles than that of /3-actin. However, the PCR
efficiencies of both /3-actin and MIA remained greater than or around 2.
Therefore, the ^ -a c tin and MIA mRNA expression levels were calculated using 2
as the PCR efficiencies (Equation 3).
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Figure 33. Real-time PCR Amplification Efficiency Determined by qpcR
The PCR efficiencies were calculated from the second derivative curve (cpD2) using the best fit b7
model. The PCR efficiency of this sample was 2.28, which was obtained from the intersection of
the green line and the blue curve at right at 30.36 cycles.
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Figure 34. /?-actin Real-Time PCR Amplification Efficiency
All the /3-actin PCR efficiencies of the single pulse experiments were obtained from the qpcR
program and were more than 2. A few outliers, which were more than 4, were observed. The
/?-actin PCR efficiency was 3.32±1.01 (mean±SD).
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Figure 35. MSA Real-Time PCR A m p lifica tio n E fficie ncy
All of the MIA PCR efficiencies of the single pulse experiments were obtained from the qpcR pro
gram and were around 2. Only one outlier was observed, which exceeded 2.5. The MIA PCR
efficiency was 2.19 ± 0 .11 (mean±SD).
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3.8 MIA mRNA EXPRESSION LEVEL AFTER A SINGLE PULSE
The cells that were seeded and immediately incubated after a single 300 ns
40 kV/cm pulse were harvested at at 6, 12, 18, and 24 h to measure their MIA
mRNA expression levels. Three replicates were conducted. Total RNA was
extracted from each cell sample. The cDNA templates were produced through
reverse transcription. The reverse transcription templates for all samples were
adjust to the same amount (200 ng total RNA). The real-time PCR templates
(cDNAs from reverse transcription) were applied at the same amount (2 uL).
Therefore, the Cq values within each group were close. Any value that deviated
from other group members was checked as a suspect outlier.
Each cDNA sample had three real-time PCR replicates. The mean Cq values
of the three replicates of each trial were calculated (Table 15). The /?—actin and
MIA cDNA level in the third trial of the control group at 6 h were omitted in the
following statistical analysis because 32.70 was an obvious outlier and no
real-time PCR raw curve was constructed for MIA. A problem may have occurred
during the reverse transcription for this sample. Manipulating reverse
transcription should be conducted more carefully in the future.

Table 15. Mean Cq Values o f /3—actin and MIA cDNA afte r a Single Pulse
Treatment 6 h
/?-actinM IA
1 Pulse

Control

12h

18h

24 h

/3-actinM IA

/3-actinM IA

^ -a c tin M IA

13.61

27.64

13.59

29.32

13.67

29.62

14.22

30.02

13.92

27.51

14.14

29.77

13.93

29.83

14.03

29.97

13.60

27.40

13.42

29.17

13.88

29.92

13.99

29.73

13.63

27.68

13.66

29.60

13.73

30.16

14.09

29.79

14.28

28.58

14.09

29.54

13.95

29.69

14.21

29.97

32.70

_

13.59

29.30

13.76

30.17

14.19

30.13

The MIA mRNA expression level was calibrated by the /3-actin for each
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sample (Equation 3, Table 16).
Calibrated MIA mRNA Expression Level = 2Cq*J- actin~CqMIA = 2~ACq

(3)
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Table 16. Calibrated MIA mRNA Expression Level after a Single Pulse
Time

Trial

Treatment

-ACq

MIA mRNA Level
(xQ.00001)

6 hours

1

One Pulse

-14.03

5.99

6 hours

2

One Pulse

-13.59

8.09

6 hours

3

One Pulse

-13.80

7.01

6 hours

1

Control

-14.06

5.88

6 hours

2

Control

-14.30

4.95

12 hours

1

One Pulse

-15.73

1.84

12 hours

2

One Pulse

-15.64

1.96

12 hours

3

One Pulse

-15.75

1.81

12 hours

1

Control

-15.94

1.59

12 hours

2

Control

-15.45

2.23

12 hours

3

Control

-15.71

1.87

18 hours

1

One Pulse

-15.95

1.58

18 hours

2

One Pulse

-15.91

1.63

18 hours

3

One Pulse

-16.04

1.49

18 hours

1

Control

-16.43

1.13

18 hours

2

Control

-15.74

1.83

18 hours

3

Control

-16.41

1.15

24 hours

1

One Pulse

-15.80

1.76

24 hours

2

One Pulse

-15.93

1.60

24 hours

3

One Pulse

-15.75

1.82

24 hours

1

Control

-15.70

1.87

24 hours

2

Control

-15.76

1.81

24 hours

3

Control

-15.93

1.60
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S tatistical test Two-factor crossed ANOVA (2x4, pure model I) with Tukey’s
follow-up test (multiple comparison and contrast for treatment). The independent
factors are he treatments and the time points. The treatment has two levels: a
single pulse group and control group. The time points have four levels: 6, 12, 18,
and 24 h. The dependent variable is the MIA mRNA expression level (calibrated
to /3-actin) of each sample. Three wells were used per treatment at each time
point (3 replicates). Two treatments were used per time point, with four time
points per treatment. A total of 24 wells (samples) were used.
Statistical hypotheses:
H 0 ’ The MIA mRNA expression level do not significantly differ between the
single pulse group and the control group excluding the time points
H a ' The MIA mRNA expression level significantly differ between the single pulse
group and the control group excluding the time points
H'0 \ The MIA mRNA expression level do not significantly differ among the
different time points excluding there treatments
H'a: The MIA mRNA expression level significantly differ among the different time
points excluding there treatments
H'q . The treatments do not significantly interact with the time points in terms of
the MIA mRNA expression levels in the cells
H"a : The treatments significantly interact with the time points in terms of the MIA
mRNA expression levels in the cells
A ssum ption checking and data tra n sfo rm a tio n s: The errors were
independent, as discussed on Page 36. Checking the residuals suggest that the
original data and the subsequent transformations (natural log, square root,
reciprocal, and exponential) did not follow a normal distribution and were
non-homogenous. Therefore, the rank values obtained from original data were
analyzed.
The results of the two-factor ANOVA (2x4, pure model I) analysis (Table 17)
indicate that the null hypothesis H'0 should be rejected in favor of the alternative
hypothesis. However, the null hypotheses (H 0 and H q ) should be accepted
instead of the alternative hypotheses, which indicate significant differences in
MIA mRNA expression levels among the different time points. The MIA mRNA
expression levels did not significantly differ between the single pulse group and
the control group. The treatments did not significantly interact with the time points
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in terms of the MIA mRNA expression levels in the cells.
The results of this study (Figure 37) indicate that the treatments did not
significantly interact with the time points (Figure 36) in terms of the MIA mRNA
expression levels in the cells (F=0.242; df=3, 15; P=0.8653). The observed
power in SPSS was 0.086. The MIA mRNA expression levels did not significantly
differ between the single pulse group and the control group (F=0.063; df=1, 15;
P=0.8059). The observed power was 0.056. Both observed powers were less
than 0.7, which indicates a high chance of false negative results. Larger sample
sizes may reduce this type of error in the future studies. The MIA mRNA
expression levels significantly differed among the different time points (F=12.053;
df=3, 15; P=0.0003). The Tukey’s multiple comparison follow-up test (Table 18)
indicated that the mean MIA mRNA expression level at 6 h was significant higher
than those at 12 h (P=0.0477), 18 h (P=0.001), and 24 h (P=0.036). The mean
MIA mRNA expression level at 12 h was significantly higher than that at 18 h
(P=0.0249). Therefore, the MIA mRNA expression level at 6 h after pulsing was
higher than those at 12, 18, and 24 h. The MIA mRNA expression levels at 12 h
after pulsing was higher than those at 18 h. If the MIA mRNA expression level at
6 h was consider 100%, that at 12 h was reduced to 29.5%, that at 18 h was
reduced to 23.0%, and that at 24 was slightly increased to 27.3%. However, the
differences between 18 h and 24 h were not significant.

Table 17. Rank o f MIA mRNA Expression Levels after a S ingle Pulse,
____________________________

Two-way Fixed ANOVA Table
Source

df

Mean

F

Significance

Square

Observed
Power

Treatment

1

1.186

0.063

0.8059

0.056

Time

3

228.599

12.053

0.0003

0.997

T reatment x Times

3

4.599

0.242

0.8653

0.086

Error

15

18.967

Total

23

Corrected Total

22
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Table 18. M ultiple C om parisons (Tukey’s) Test
(I) Time

(J) Time

6 hours

12 hours

12 hours

18 hours

24 hours

Std. Error

Significance

7.6667

2.63713

0.0477

18 hours

15.8333

2.63713

0.0001

24 hours

11.1667

2.63713

0.0036

6 hours

-7.6667

2.63713

0.0477

18 hours

8.1667

2.51440

0.0249

24 hours

3.5000

2.51440

0.5229

-15.8333

2.63713

0.0001

12 hours

-8.1667

2.51440

0.0249

24 hour

-4.6667

2.51440

0.2872

6 hours

-11.1667

2.63713

0.0036

12 hours

-3.5000

2.51440

0.5229

18 hours

4.6667

2.51440

0.2872

6 hours

Mean Difference (l-J)
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Figure 36. MIA mRNA Interaction Graph
The attached cells after a single 300 ns 40 kV/cm pulse and those in the unpulsed groups were
harvested using trypsin-EDTA treatment after 6, 12, 18, and 24 h of culture. Total RNA were ex
tracted from each cell sample. Three replicates were conducted. cDNA was produced from the
total RNA using reverse transcription. Exactly 200 ng of cDNA template was employed in each
real-time PCR. Each sample had a real-time PCR triplet. SYBR Green fluorescence was detected,
and the Cq values of all reactions were calculated. The MIA mRNA expression levels were cali
brated using /?—actin as the internal control. Two-way fixed ANOVA indicated that the treatments
did not significantly interact with the time points in terms of the mean MIA mRNA expression levels
in the cells (F=0.242; df=3, 15; P=0.8653), n=3.
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Figure 37. MIA mRNA expression levels (calibrated with /3-actin) after a
Single Pulse
The attached cells after a single 300 ns 40 kV/cm pulse and those in the unpulsed group were
harvested using trypsin-EDTA treatment after 6, 12, 18, and 24 h of culture. Total RNA were ex
tracted from each cell sample. Three replicates were conducted. cDNA was produced from the
total RNA through reverse transcription. Exactly 200 ng of cDNA template was employed in each
real-time PCR. Each sample had a real-time PCR triplet. SYBR Green fluorescence was detected,
and the Cq values of all reactions were calculated. The MIA mRNA expression level were cali
brated using /?-actin as the internal control. The MIA mRNA expression levels did not significanty
differ between the single pulse group and control group (F=0.063; df=1, 15; P=0.8059). The MIA
mRNA expression levels significantly differed among the different time points (F=12.053; df=3, 15;
P=0.0003). The Tukey’s multiple comparison follow-up test indicated that the mean MIA mRNA
expression levels at 6 h was significantly higher than those at 12 h (P=0.0477), 18 h (P=0.001),
and 24 h (P=0.036). The mean MIA mRNA expression levels at 12 h was significantly higher than
that at 18 h (P=0.0249). The data shown are means±SEM, n=3.
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3.9 MIA MRNA EXPRESSION LEVEL AFTER MULTIPLE PULSES
The cells were immediately seeded and cultured after two, three, and four 300
ns 40 kV/cm pulses to measure the MIA mRNA expression levels. The cells were
harvested using trypsin-EDTA treatment at 6, 12, 18, and 24 h. Three replicates
were conducted. Total RNA were extracted from each cell sample. The cDNA
templates were produced through reverse transcription. The reverse transcription
templates for all samples were adjusted to the same amount (100 ng total RNA).
The real-time PCR templates (cDNAs from reverse transcription) were applied at
the same amount (2 /iL). Therefore, the Cq values within each group were close.
Any value that deviated from the other group members was checked as a
suspect outlier. Each cDNA sample had three real-time PCR replicates. The
mean Cq values of the three replicates were then calculated (Table 19).

Table 19. Mean Cq Values o f /3 -a ctin and MIA cD N A a fte r M ultiple Pulses
Treatment 6 h
/?-actin MIA
Control

2 Pulses

3 Pulses

4 Pulses

12 h

18 h

24 h

/3-actin MIA

/3-actin MIA

(3- actin MIA

15.87

31.20

15.30

30.68

15.18

33.17

15.40

33.29

14.93

30.24

14.57

30.92

15.30

33.10

14.88

34.14

14.97

29.56

15.11

31.35

14.19

32.21

14.71

32.43

17.88

31.41

16.09

31.80

15.17

32.21

15.92

33.41

16.55

31.17

16.18

31.51

15.12

33.33

15.51

34.33

16.62

30.50

15.86

31.02

15.61

33.32

15.26

32.63

15.83

30.56

17.32

32.26

15.44

33.62

16.54

33.57

16.57

30.99

14.54

30.23

15.34

31.95

16.37

34.37

17.32

31.18

15.59

31.80

15.69

32.74

15.49

32.94

17.40

31.96

16.17

32.05

16.14

32.52

16.43

34.01

17.07

31.03

16.02

31.41

17.44

34.30

17.08

34.16

17.34

30.72

16.87

31.41

15.53

32.59

16.55

33.88

The MIA mRNA expression levels were calibrated using /?-actin (Table 20
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and 21), as previously described for the single pulse.
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Table 20. Calibrated MSA mRNA E xpression Level afte r M ultiple Pulses (6 h
and 12 h)
Time/Treatment

-ACq

MIA mRNA Level (x 0.00001)

-15.33

2.42

-15.31

2.47

-14.60

4.04

-13.53

8.43

-14.62

3.97

-13.87

6.66

-14.73

3.68

-14.42

4.55

-13.86

6.73

-14.56

4.15

-13.97

6.25

-13.38

9.36

-15.38

2.35

-16.35

1.20

-16.23

1.30

-15.70

1.87

-15.32

2.44

-15.16

2.73

-14.94

3.17

-15.69

1.89

-16.22

1.31

-15.88

1.66

-15.39

2.33

-14.55

4.18

6 hours
Control

2 Pulses

3 Pulses

4 Pulses

12 hours
Control

2 Pulses

3 Pulses

4 Pulses
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Table 21. Calibrated S¥3!A mRNA E xpression Level a fte r M u ltiple Pulses (18 h
and 24 h)
Time/Treatment

-ACq

MIA mRNA Level ( x 0.00001)

-17.99

0.38

-17.80

0.44

-18.02

0.38

-17.04

0.74

-18.21

0.33

-17.71

0.47

-18.18

0.34

-16.61

1.00

-17.05

0.74

-16.38

1.17

-16.86

0.84

-17.06

0.73

-17.89

0.41

-19.26

0.16

-17.72

0.46

-17.49

0.54

-18.82

0.22

-17.37

0.59

-17.03

0.75

-18.01

0.38

-17.45

0.56

-17.58

0.51

-17.08

0.72

-17.33

0.61

18 hours
Control

2 Pulses

3 Pulses

4 Pulses

24 hours
Control

2 Pulses

3 Pulses

4 Pulses
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S tatistical test: Two-factor crossed ANOVA (4x4, pure model I) with Tukey’s
follow-up tests (multiple comparison and contrast for treatments and time points).
The independent factors were the treatments and time points. The treatments
have four levels: the two-, three-, and four-pulse groups and the control group.
The time points have four levels: 6, 12, 18, and 24 h. The dependent variable was
the MIA mRNA expression levels of each sample (calibrated with /3-actin). Three
wells per treatment were used per time point (3 replicates) with four treatments
per time point and four time points per treatment. A total of 48 wells (samples).
S tatistical hypotheses:
H 0 : The MIA mRNA expression levels do not significantly differ among the
control group and the two-, three-, and four-pulse groups excluding the time
points
Ha : The MIA mRNA expression levels significantly differ among the control
group and the two-, three-, and four-pulse groups excluding the time points
H'0 : The MIA mRNA expression levels do not significantly differ among the
different time points excluding the treatments
H'a : The MIA mRNA expression levels significantly differ among the different
time points excluding the treatments
H'o- The treatments do not significantly interact with the time points in terms of
the mean MIA mRNA expression levels in the cells
Ha : The treatments significantly interact with the time points in terms of the
mean MIA mRNA expression levels in the cells
A ssum ption checking and data tra n sfo rm a tio n s: The errors were
independent as previously discussed in the single pulse treatments. The raw
data were normally distributed, but hon-homogenous. Thus, the residues were
tested again for normality and homogeneity using the raw -ACq values, square
root, reciprocal, and exponential transformations. Only the residues of raw -ACq
values were normally distributed and homogenous. Therefore, the raw -ACq
values were used for the two way ANOVA.
The results of the two way ANOVA (4x4, pure model I) indicated that the null
hypotheses (H 0 and H'0 ) should be rejected in favor of the alternative
hypotheses (Table 22). However, the null hypothesis (H 0 ,’) should be accepted
instead of the alternative hypothesis, which indicates a significant difference in
MIA mRNA expression levels among the treatments and among the different time
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points, but the treatments did not significantly interact with the time points in
terms of the mean MIA mRNA expression levels in the cells.
The ANOVA results of this experiment indicate that the treatments did not
significantly interact with the time points in terms of the MIA mRNA expression
levels in the cells (F=0.413; df=9, 32; P=0.919) (Figure 38). The observed power
in SPSS was 0.169, which is less than 0.7 and indicates a high chance of false
negative results. Larger sample sizes may reduce this type of error in future
studies. The MIA mRNA expression levels significantly differed among the
control group, the two-pulse group, three-pulse group, and the four-pulses group
(F=6.408; df=3, 32; P=001594) (Figure 39). The observed power was 0.948. The
MIA mRNA expression levels significantly differed among the different time points
(F=97.647; df=3, 32; P<0.0000005). The observed power was 1.000.
The Tukey’s multiple comparison follow-up for the different time points
indicated that the mean MIA mRNA expression level at 6 h was significantly
different from those at 12 h (P=0.000044), 18 h (P<0.000001), and 24 h
(P<0.000001) (Table 23). The mean MIA mRNA expression level at 12 h was
also significant different from that at 18 h (P<0.000001) and 24 h (P<0.000001).
The mean MIA mRNA expression level at 18 hours was no significant different
from that at 24 h (P=0.447615). Therefore, the MIA mRNA expression level at 6 h
after pulsing was significantly higher than those at 12, 18, and 24 h. The MIA
mRNA expression level at 12 h after pulsing was also significantly higher than
those at 18 and 24 h.
The Tukey’s multiple comparison follow-up test for the different time points
(Table 24) indicated that the mean MIA mRNA expression level after two pulses
did not significantly differ from those of the control group (P=0.070), the
three-pulse group (P=0.995) and the four-pulse group (P=0.312). The mean MIA
mRNA expression level after three pulses significantly differed from that of the
control group (P=0.041), but had not from those of the two-pulse group (P=0.995)
and the four-pulse group (P=0.439). The mean MIA mRNA expression level of
the four-pulse group significantly differed from that of the control group
(P=0.001), but not from those of the two-pulse group (P=0.312) and the
three-pulse group (P=0.439). Therefore, the MIA mRNA expression levels of the
three-pulse and four-pulse groups were significantly higher than that of the
control group, but that of the two-pulse group was not significantly higher than
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that of the control group.

Table 22. Raw -ACq o f MSA mRNA Expression Level a fte r M ultiple Pulses,
Two-way Fixed ANOVA Table
Source

df

Mean

F

Significance

Observed
Power

Square
Time

3

30.724

97.647

<0.0000005

1.000

Pulses

3

2.016

6.408

0.001594

0.948

Timex Pulses

9

0.130

0.413

0.918629

0.169

Error

32

0.315

Total

48

Corrected Total

47
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Table 23. M ultiple C om parisons (Tukey’s) Test fo r D iffe ren t Time Points
(1) Time

(J) Time

Mean

Differ-

Std. Error

Significance

ence (l-J)
6 hours

12 hours

18 hours

24 hours

12 hours

1.219444

0.228998760

0.000044

18 hours

3.060278

0.228998760

<0.000001

24 hours

3.404444

0.228998760

<0.000001

-1.219444

0.228998760

0.000044

18 hours

1.840833

0.228998760

<0.000001

24 hours

2.185000

0.228998760

<0.000001

6 hours

-3.060278

0.228998760

<0.000001

12 hours

-1.840833

0.228998760

<0.000001

24 hour

0.344167

0.228998760

0.447615

6 hours

-3.404444

0.228998760

<0.000001

12 hours

-2.185000

0.228998760

<0.000001

18 hours

-0.344167

0.228998760

0.447615

6 hours

Table 24. M ultiple C om parisons (Tukey’s) Test fo r M ultiple Pulses
(I) Time

(J) Time

Mean

Differ

Std. Error

Significance

ence (l-J)
Control

2 Pulses

3 Pulses

4 Pulses

2 Pulses

-0.5858333

0.228998760

0.070

3 Pulses

-0.6405556

0.228998760

0.041

4 Pulses

-0.9883333

0.228998760

0.001

0.5858333

0.228998760

0.070

3 Pulses

-0.5472222

0.228998760

0.995

4 Pulses

-0.4025000

0.228998760

0.312

Control

0.6400556

0.228998760

0.041

2 Pulses

0.0547222

0.228998760

0.995

4 Pulses

-0.3477778

0.228998760

0.439

Control

0.9883333

0.228998760

0.001

2 Pulses

0.4025000

0.228998760

0.312

3 Pulses

0.3477778

0.228998760

0.439

Control
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Figure 38. SVilA mRNA Interaction Graph after M ultiple Pulses
The attached cells after two, three, and four 300 ns 40 kV/cm pulses, as well as in the unpulsed
group were harvested using trypsin-EDTA treatment after 6, 12, 18, and 24 h of culture. Total RNA
were extracted from each cell sample. Three replicates were conducted. The cDNA was produced
from the total RNA using reverse transcription. Exactly 200 ng of the cDNA template was employed
in each real-time PCR. Each sample had a real-time PCR triplet. SYBR Green fluorescence was
detected, and the Cq values of all the reactions were calculated. The MIA mRNA expression levels
were calibrated using

actin as the internal control. The treatments did not significantly interact

with the time points in terms of the MIA mRNA expression levels in the cells (F=0.413; df=9, 32;
P=0.919), n=3.
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Figure 39. MIA mRNA Expression Level (calibrated to /3 -a c tin ) after
M ultiple Pulses
The attached cells after two, three, and four 300 ns 40 kV/cm pulses, as well as in the unpulsed
group were harvested using trypsin-EDTA treatment after 6, 12, 18, and 24 h of culture. Total RNA
were extracted from each cell sample. Three replicates were conducted. The cDNA was produced
from the total RNA using reverse transcription. Exactly 200 ng of the cDNA template was employed
in each real-time PCR. Each sample had a real-time PCR triplet. SYBR Green fluorescence was
detected, and the Cq values of all the reactions were calculated. The MIA mRNA expression
levels were calibrated using /?-actin as the internal control. The mean MIA mRNA expression
levels at 6 h was significant higher than that at 12 h (P=0.000044), 18 h (P<0.000001), and 24 h
(P<0.000001). The mean MIA mRNA expression level at 12 h was significantly higher than that at
18 h (P<0.000001) and 24 h (P<0.000001). The mean MIA mRNA expression level at 18 h was
not significant different from that at 24 h (P=0.447615). The mean MIA mRNA expression level of
the two-pulse group did not significantly differ from those of the control (P=0.070), the three-pulse
group (P=0.995), and the four-pulse group (P=0.312). The mean MIA mRNA expression level of
the three-pulse group was significantly higher than that of the control group (P=0.041), but not from
that of the two-pulse group (P=0.995) and the four-pulse group (P=0.439). The mean MIA mRNA
expression level of the four-pulse group was significantly higher than that of the control group
(P=0.001) but not from that of the two-pulse group (P=0.312) and the three-pulse group (P=0.439).
The data shown are means±SEM, n=3.
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CHAPTER 4

d is c u s s io n

4.1 CELL ATTACH ABILITY CHANGES AFTER nsEPS
The number of floating live, dead, and total cells after a single pulse did not
significantly differ between the control group and single pulse groups (P=0.511,
0.736, 0.828, respectively) (Figure 10). This result indicates that the cells have
no significantly different attachment abilities. The cells in the control group and
single pulse groups had similar cell densities based on the cell micrographs at 6,
12, 18, and 24 h (Figures 15 and 16), which indicates that the number of attached
cells in the control group did not significantly differ from those of the single pulse
group. Therefore, a single pulse does not affect the attachment ability of the cells.
The results of the long-term cell viability test (Figure 22) after two, three, and
four pulses indicated that the percentage of attached live cells in the control
significantly differed from those of the two-, three, and four-pulse groups
(F=10.724; df=3, 32; P<0.00005). The percentage of attached live cells at 24 h
was significantly higher than at 6, 12, and 18 h (all P<0.05), which indicates that
the cell attachment ability gradually recovered after 24 h. The two-, three-, and
four-pulse groups significantly decreased the percentage of attached live cells
(P=0.014, 0.004, 0.00002, respectively), which indicates that the two-, three-, and
four-pulse treatments decreased the cell attachment ability within 24 h.
Therefore, the two, three, and four 300 ns 40 kV/cm pulses significantly
inhibited the attachment of melanoma cells onto the plate surface. A single pulse
did not change the cell attachment ability. This result is very promising for future
clinical use to inhibiting melanoma metastasis. Cell attachment and cell adhesion
plays an important role in spreading tumor cells through the circulatory system
(cell migration) and in establishing new tumors. Inhibition of the melanoma cell
attachment provides an opportunity to reduce new tumor formation and slow
down the metastatic process.
This study explored a new field in the nsEPs effect on melanoma cells. We
found that nsEPs has great potential in inhibiting the cell attachment ability,
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especially that of cancer cells. However, the mechanism remains unclear. The
role played by cell adhesion molecules (CAMs), such as integrins, in
nsEP-induced inhibition of attachment is unknown. In the future, CAMs could be
targeted to investigate the inhibitory effect of nsEPs on cell attachment or cell
adhesion.
4.2 CELL MORPHOLOGY CHANGES AFTER nsEPS
The results of the cell morphology test after a single 300 ns 40 kV/cm pulse
indicated that cells were spread out, formed spines, and became spindle-shaped
in both the control group and the single pulse group (Figure 15). No significant
morphologic differences were observed between the control group and the single
pulse group, which is consistent with the cell attachment ability in the single pulse
experiments. Therefore, single pulses do not affect cell attachment ability and
morphology.
The results of the cell morphology test after multiple pulses (Figures 23 - 26)
show significant decreases in cell spread area at 6, 12, 18, and 24 h after two-,
three-, and four-pulse treatments. The two-, three-, and four-pulse treatments
significantly decreased the frequency of nuclear division, based on the changes
in nuclear shape. Furthermore, multiple pulses greatly slowed cell attachment.
Therefore, two, three, and four 300 ns 40 kV/cm pulses decrease the cell
attachment area, slow down the attachment process, and inhibit nuclear division.
Single pulse did not change the cell attachment area, the attachment process,
and nuclear division. These results verify the cell attachment ability study shown
above, wherein two-, three-, and four-pulse treatments significantly inhibited cell
attachment and adhesion. Nuclear division occurs during cell proliferation. Thus,
nsEPs could significantly inhibit cell attachment, cell adhesion, and cancer cell
proliferation. These strong indications suggest that nsEPs have great potential
for inhibiting melanoma metastasis.
The limitation of this morphologic study is the lack of quantitative results.
Everything was examined through direct visualization. In the future, cell cycle
markers, such as propidium iodide (PI) and 7-aminoactinomycin D (7-AAD), and
cell proliferation markers, such as Violet Proliferation Dye 450 (VPD450), can be
used to quantify the cell cycle distribution and cell proliferation through flow
cytometry. CAMs can also be stained through immunohistochemistry (IHC),
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which would provide location information for the attachment study.

4.3 LOWG-TERM VIABILITY TEST AFTER nsEPS
The results of the long-term viability test after multiple pulses revealed that the
total cell viability of the control group (around 90%) was significantly higher than
that of the two-, three-, and four-pulse groups (all P<0.0001; Figure 18). The total
cell viability of the two-pulse group (around 40%) was significantly higher than
those of the three-pulse and four-pulse groups (around 20%; all P 0 .0 0 0 1 ). The
total cell viability did not significantly differ between the three-pulse group and the
four-pulse group.
Therefore, the two-pulse treatment significantly decreases the total viability of
the cells; the three-pulse and four-pulse treatments further decrease the cell
viability. This nsEPs-induced decrease in cell viability may be related to cell
apoptosis or cell necrosis. Previous research revealed that nsEPs trigger
apoptosis-like mechanisms to activate caspase release (Ford et al., 2010). The
research found that B16-F10 melanoma cells released significantly high amounts
of caspase within 1 h of ten 300 ns 40 kV/cm pulses compared with the control.
The cell survivability of the 10-pulse group was significantly low compared with
that of the control group. Therefore, nsEP-induced apoptosis can decreases cell
viability. Our results are consistent with those of a previous study.
The inhibitory effect of nsEP on cell viability provides a new method for
reducing tumor size and indirectly confining the tumor in its original location.
Therefore, nsEPs may be a good choice for treating metastatic melanomas in
clinical trials.
The limitation of our research is that we determined the cell density and the
number of floating cells after a single 300 ns 40 kV/cm pulse, but not the
corresponding cell viability. Although the cell density and the number of floating
cells did not significantly differ between the single pulse group and the control
group, we can only deduce that single pulses do not affect cell viability.
Therefore, cell viability after single 300 ns 40 kV/cm pulse should be tested in
future studies.

4.4 PCR EFFICIENCIES
The theoretical amplification efficiency ranged from 1 to 2. An efficiency of 1
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indicates no amplification, whereas 2 indicates that the amount of
double-stranded DNA doubled during each PCR cycle. Normal amplification
efficiencies ranges from 1.8 to 2. Amplification efficiency is influenced by primer
quality and design, PCR inhibitors in the PCR reagents or samples, and the
availability of dNTPs, amplification enzymes, and other factors. Both LinRegPCR
and qpcR provide amplification efficiencies and other important parameters.
The advantage of LinRegPCR is that it allows adjustment of the slope to a
certain extent based on the raw data point. The resulting amplification efficiency
still has some bias because the software does not allow free adjustment of the
slope. The resulting mean efficiency was > 2. The melting curves of /?-actin and
MIA both showed only one peak, which excludes the possibility of primer dimers
or non-specific amplification. Therefore, calculating efficiency using LinRegPCR
is still valid even though the mean efficiency was >2. LinRegPCR still has room
for improvement, e.g., manual slope adjustment and support for Mac and Linux
systems.
The advantage of the qpcR package is that it allows the use of different
parameters in calculating efficiency at different points of the raw data curve. The
slope of the curve cannot be adjusted manually, which introduces a bigger bias
(efficiency is much greater than 2). However, the efficiency results remain valid
because of 2 is within their mean±SEM range. The other advantage of qpcR is
support for all systems: Windows, Mac, and Linux.
The PCR efficiency of /3-actin was slightly higher than that of MIA, which may
be caused by the larger amount of ^ -a c tin than MIA in the sample. The Cq
values of MIA are 10 cycles greater than that of /?—actin. The PCR reagents may
have less activity than that form the previous 10 cycles because the MIA reaction
requires a longer period to reach the fluorescence threshold. Thus, the MIA PCR
efficiency is slightly lower. However, the MIA PCR efficiency remains around 2;
thus, a PCR efficiency of 2 is valid for both /3-actin and MIA.
4.5 MIA MRNA EXPRESSION LEVEL AFTER nsEPS
The MIA mRNA expression levels in the single 300 ns 40 kV/cm pulse group
did not significantly differ from those of the control group (F=0.063; df=1, 15;
P=0.8059; Figure 37). Therefore, one 300 ns 40 kV/cm electric pulse does not
inhibit or stimulate MIA mRNA expression in murine B16-F10 melanoma cells.
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The MIA mRNA expression levels decreased with time, from 100% at 6 h to
29.5% at 12 h, to 23.0% at 18 h, and then to 27.3% at 24 h. Therefore, MIA
mRNA expression has a sloped pattern.
This sloped pattern may be due to growth disturbance during the experiment
such as the trypsin treatment, centrifugation, low nutrient concentrations in PBS,
and room temperature exposure. When the cells are seeded into the plate and
cultured in the incubator after those operations, the environment and nutrients
are optimal for cell growth. Cells largely express growth regulators, such as MIA.
Thus, the MIA mRNA expression levels were high at 6 h. MIA mRNA is
translated into MIA protein after its transcription. MIA stimulates the expression of
downstream growth-related genes. MIA mRNA was produced within a very short
period. Thus, the MIA mRNA level decreased to 29.5% at 12 h. MIA mRNA
degrades continuously. The MIA mRNA level further decreased to 23.0% at 18 h.
The cells grew thereafter; thus, the MIA mRNA levels increased to 27.3%, but the
change was not significant. Therefore, a sloped pattern formed.
The MIA mRNA expression levels in the three-pulse and the four-pulse
groups were significantly higher than that in the control group (Figure 39;
P=0.041, 0.001, respectively). The MIA mRNA expression levels did not
significantly differ between the control group and the two-pulse group (P=0.070).
The MIA mRNA expression level at 6 h was significantly higher than those at 12,
18, and 24 h (P=0.000044, P<0.000001, and P<0.000001, respectively). The
MIA mRNA expression level at 12 h was significantly higher than that at 18 and at
24 h (both P<0.000001). The MIA mRNA expression levels did not significantly
differ between the 18 h and the 24 h time points (P=0.447615).
These results indicate that three-pulse and four-pulse treatments is
significantly increase the MIA mRNA expression levels, whereas one-pulse and
two-pulse treatments do no.The MIA mRNA expression level gradually
decreased from the 6 h time point to the 18 h time point. The MIA mRNA
expression level did not significantly differ between the 18 h time point and the 24
h time point. These results indicate that the MIA mRNA expression level
gradually decreases within 24 h. However, three-pulse and four-pulse treatments
increase MIA mRNA expression, thereby increasing metastatic potential.
This research shows that three and four 300 ns 40 kV/cm electric pulses
increase the MIA mRNA expression level. The MIA expression levels after three
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or four pulses were only slightly different from that of the control group at 18 and
24 h. Therefore, the MIA mRNA expression level was significantly increased
within 12 h but reduced almost to normal between 12 h and 24 h. Total cell
viability was also significantly decreased (more than half), and the cell
attachment ability and cell nuclear division were decreased. These results are
encouraging for the treatment of metastatic melanomas because nsEPs inhibits
the adhesion and proliferation of metastatic melanoma cells. The two-pulse
treatment did not significantly increase the MIA mRNA expression levels, but
significantly decreased cell attachment ability and nuclear division, as well as
changed the cell morphology. Three-pulse and four-pulse increased the MIA
mRNA expression levels within 12 h, which returned to normal after the next 12
h. Thus, two-, three-, and four-pulse treatments optimally inhibit melanoma
metastasis and cell attachment.
The mechanism by which nsEPs stimulate MIA mRNA expression is still
unknown. Furthermore, studies on nsEP-induced mRNA degradation are still
unavailable. Thus, information regarding the effects of nsEPs on MIA mRNA
expression is limited. More research should be done to explore the benefits of
nsEPs.
More time points and replicates are needed to test the slope, such as at 6, 12,
18, and 24 h before the pulses and at 30, 36, 42, and 48 h after the pulses.
These time points can also be closer together such as at 0.5, 1, 2, and 3 h after
the pulses. The cells may also be grown on the cover slides or pulsing cuvette, to
which the electric pulses could be directly applied, to reduce trypsin-EDTA
treatment and other disturbances.
Our pilot study shows that the one-, two-, three-, and four-pulse groups and
the control group do not significantly differ in lysozyme structure (data not
shown). This finding indicates that some protein structures remain unchanged
under nsEPs, which is very promising for nsEP treatment because normal
proteins should be unaffected. Furthermore, methods for detecting the amount of
protein, such as western blot and ELISA, can be used to measure MIA protein
concentration.
This study opens a new field for treating metastatic melanomas using
nanosecond high-voltage electric pulses. Further studies are needed to develop
this new field and benefit humans and other organisms.
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CHAPTER 5

CONCLUSIONS

We have demonstrated the changes in cell attachment ability within the 24 h
after nsEP treatment. A single 300 ns 40 kV/cm pulse did not affect attachment
ability and cell morphology. The two, three, and four 300 ns 40 kV/cm pulses
significantly decreased cell attachment ability (P=0.014, 0.004, 0,00002,
respectively), cell attachment area, as well as slowed down the attachment
process, and inhibited nuclear division for 24 h. The cell attachment ability
gradually recovered after 24 h, but it did not to its normal value. Treatment with
more pulses more strongly inhibited the cell attachment ability.
We also demonstrated the changes in cell viability within 24 h after the nsEP
treatment. A single 300 ns 40 kV/cm pulse did not affect cell viability. However,
two, three, and four 300 ns 40 kV/cm pulses significantly decreased cell viability
(more than half; all P<0.0001). More than half of the cells died after the two-,
three-, and four-pulse treatments.
We determined the MIA mRNA expression levels within 24 h after the nsEP
treatment. Treatment with one or two 300 ns 40 kV/cm pulses did not affect MIA
mRNA expression, whereas three or four 300 ns 40 kV/cm pulses significantly
increased the MIA mRNA expression levels within 6 and 12 h, but remained close
to normal within 18 and 24 h (P=0.041, 0.001, respectively). Considering MIA is a
marker for melanoma metastasis, treatment with three or four pulses increases
the risk of melanoma metastasis within the first 12 h of pulsing but only slightly
after the following 12 h.
We conclude that a single 300 ns 40 kV/cm pulse does not change the
attachment ability, morphology, and MIA mRNA expression levels of murine
B16-F10 melanoma cells within 24 h. Three to four 300 ns 40 kV/cm pulses
significantly decreased the cell attachment ability, cell viability, nuclear division,
and the cell attachment area, but significantly increased the MIA mRNA
expression levels within the first 12 h after pulsing. Treatment with two 300 ns 40
kV/cm pulses significantly decreased cell attachment ability, cell viability, and cell

109

attachment area, but did not significantly increase the MIA mRNA expression
levels within the first 24 h after pulsing.
Therefore, treatment with two, three, or four 300 ns 40 kV/cm pulses reduces
cell attachment ability, and cell viability. Although the MIA mRNA expression
levels increased within the first 12 h, the increase during the second 12 h after
the pulse treatments was not much. Treatment with two to four 300 ns 40 kV/cm
pulses is optimal for treating metastatic melanomas.

110

REFERENCES

Al-Sakere, B., Andre, F., Bernat, C., Connault, E., Opolon, P., Davalos, R.V.,
Rubinsky, B., and Mir, L.M. (2007), Tumor ablation with irreversible
electroporation. PLoS One 2, e1135.
Angres, B., Barth, A., and Nelson, W.J. (1996), Mechanism for transition from
initial to stable cell-cell adhesion: kinetic analysis of E-cadherin-mediated
adhesion using a quantitative adhesion assay. The Journal of Cell Biology 134,
549-557.
Arunkumar, M.J., Ranjan, A., Jacob, M., and Rajshekhar, V. (2001),
Neurocutaneous melanosis: a case of primary intracranial melanoma with
metastasis. Clin Oncol 13, 52-54.
Aung, P., Oue, N., Mitani, Y., Nakayama, H., Yoshida, K., Noguchi, T., Bosserhoff,
A., and Yasui, W. (2005), Systematic search for gastric cancer-specific genes
based on SAGE data: melanoma inhibitory activity and matrix
metalloproteinase-10 are novel prognostic factors in patients with gastric cancer.
Oncogene 25, 2546-2557.
Bauer, R., Humphries, M., Fassler, R., Winklmeier, A., Craig, S.E., and
Bosserhoff, A.K. (2006), Regulation of integrin activity by MIA. Journal of
Biological Chemistry 281, 11669-11677.
Beebe, S.J., Fox, P.M., Rec, L.J., Willis, E.L.K., and Schoenbach, K.H. (2003),
Nanosecond, high-intensity pulsed electric fields induce apoptosis in human
cells. The FASEB Journal 17, 1493-1495.
Beebe, S.J., Schoenbach, K.H., and Heller, R. (2010), Bioelectric applications for
treatment of melanoma. Cancers 2, 1731-1770.
Blesch, A., Bofcerhoff, A.K., Apfel, R., Behl, C., Hessdoerfer, B., Schmitt, A.,
Jachimczak, P., Lottspeich, F., Buettner, R., and Bogdahn, U. (1994), Cloning of a
novel malignant melanoma-derived growth-regulatory protein, MIA. Cancer
Research 54, 5695-5701.

111

Bogdahn, U., Apfel, R., Hahn, M., Gerlach, M., Behl, C., Hoppe, J., and Martin, R.
(1989), Autocrine tumor cell growth-inhibiting activities from human malignant
melanoma. Cancer Research 49, 5358-5363.
Bosserhoff, A. and Buettner, R. (2002), Expression, function and clinical
relevance of MIA (melanoma inhibitory activity). Histol Histopathol. 17, 289-300.
Bosserhoff, A.K., Echtenacher, B., Hein, R., and Buettner, R. (2001), Functional
role of melanoma inhibitory activity in regulating invasion and metastasis of
malignant melanoma cells in vivo. Melanoma Research 11, 417-421.
Bosserhoff, A.K., Kaufmann, M., Kaluza, B., Bartke, I., Zimgibl, H., Hein, R.,
Stolz, W., and Buettner, R. (1997a), Melanoma-inhibiting activity, a novel serum
marker for progression of malignant melanoma. Cancer Research 57,
3149-3153.
Bosserhoff, A.K., Kondo, S., Moser, M., Dietz, U.H., Copeland, N.G., Gilbert,
D.J., Jenkins, N.A., Buettner, R., and Sandell, L.J. (1997b), Mouse CD-RAP/MIA
gene: Structure, chromosomal localization, and expression in cartilage and
chondrosarcoma. Developmental Dynamics 208, 516-525.
Bosserhoff, A.K., Moser, M., Hein, R., Landthaler, M., and Buettner, R. (1999), In
situ expression patterns of melanoma-inhibiting activity (MIA) in melanomas and
breast cancers. The Journal of Pathology 187, 446-454.
Bosserhoff, A.K., Stoll, R., Sleeman, J.P., Bataille, F., Buettner, R., and Holak,
T.A. (2003), Active detachment involves inhibition of cell-matrix contacts of
malignant melanoma cells by secretion of melanoma inhibitory activity.
Laboratory Investigation 83, 1583-1594.
Buzbee, T.M. and Legha, S.S. (1992), Spontaneous rupture of spleen in a patient
with splenic metastasis of melanoma. A case report. Tumori 78, 47-48.
Cemil, B., Emmez, H., Oztanir, N., Tokgoz, N., and Dogulu, F. (2008), A cystic
amelanotic melanoma metastasis to the brain: case report. Neurocirugia 19,
365-367.

112

Chrissos, D.N., Stougiannos, P.N., Mytas, D.Z., Katsaros, A.A., Andrikopoulos,
G.K., and Kallikazaros, I.E. (2008), Multiple cardiac metastases from a malignant
melanoma. Eur J Echocardiogr 9, 391-392.
De Vries, T., Fourkour, A., Punt, C., Diepstra, H., Ruiter, D., and Van Muijen, G.
(1999), Melanoma-inhibiting activity (MIA) mRNA is not exclusively transcribed in
melanoma cells: low levels of MIA mRNA are present in various cell types and in
peripheral blood. British Journal of Cancer 81, 1066.
Dietz, U.H. and Sandell, L.J. (1996), Cloning of a retinoic acid-sensitive mRNA
expressed in cartilage and during chondrogenesis. Journal of Biological
Chemistry 271, 3311-3316.
El Fitori, J., Kleeff, J., Giese, N.A., Guweidhi, A., Bosserhoff, A.K., Buchler, M.W.,
Friess, H., et al. (2005), Melanoma Inhibitory Activity (MIA) increases the
invasiveness of pancreatic cancer cells. Cancer Cell Int 5.
Ford, W.E., Ren, W., Blackmore, P.F., Schoenbach, K.H., and Beebe, S.J. (2010),
Nanosecond pulsed electric fields stimulate apoptosis without release of
pro-apoptotic factors from mitochondria in B16f10 melanoma. Archives of
Biochemistry and Biophysics 497, 82-89.
Guba, M., Bosserhoff, A., Steinbauer, M., Abels, C., Anthuber, M., Buettner, R.,
and Jauch, K. (2000), Overexpression of melanoma inhibitory activity (MIA)
enhances extravasation and metastasis of A-mel 3 melanoma cells in vivo.
British Journal of Cancer 83, 1216.
Hashemi, M., Stark, A., Hugo, H., and Mehdorn, M. (2009), Intracranial trigeminal
nerve metastasis of a desmoplastic neurotropic melanoma: case report. Cent Eur
Neurosurg 70, 91-94.
Hoang, M.T. and Eichenfield, L.F. (2000), The rising incidence of melanoma in
children and adolescents. Dermatol Nurs 12, 188-189, 192-193.
Houmsse, M., Raman, S.V., Leier, C.V., and Orsinelli, D.A. (2004), Metastatic
melanoma of the left ventricle: cardiac imaging in the diagnosis and surgical
approach. Int J Cardiovasc Imaging 20, 523-528.

113

Howlader, N., Noone, A., Krapcho, M., Neyman, N., Aminou, R., Altekruse, S.,
Kosary, C., Ruhl, J., Tatalovich, Z., Cho, H., et al. (2012), SEER cancer statistics
review, 1975-2009 (vintage 2009 populations). Bethesda, MD: National Cancer
Institute .
Jemal, A., Siegel, R., Ward, E., Hao, Y., Xu, J., Murray, T., and Thun, M.J. (2008),
Cancer statistics, 2008. CA: A Cancer Journal for Clinicians 58, 71-96.
Kopf, A.W., Rigel, D.S., and Friedman, R.J. (1982), The rising incidence and
mortality rate of malignant melanoma. J Dermatol Surg Oncol 8, 760-761.
Kubota, Y., Tomita, Y., Tsukigi, M., Kurachi, H., Motoyama, T., and Mir, L.M.
(2005), A case of perineal malignant melanoma successfully treated with
electrochemotherapy. Melanoma Research 15, 133.
Kurul, S., Aykan, F., and Tas, F. (2006), Penile metastasis of cutaneous malignant
melanoma: a true hematogenous spread?: Case report and review of the
literature. Melanoma Research 16, 259-261.
Langley, R.R. and Fidler, I.J. (2011), The seed and soil hypothesis revisited-the
role of tumor-stroma interactions in metastasis to different organs. Int J Cancer
128, 2527-2535.
Lesur, G., Bourgault, I., Longvert, C., El Hajjam, M., Dubreuil, O., Julie, C., Saiag,
P., and Clerici, T. (2009), [Rectosigmoid junction metastasis from melanoma: a
case report]. Gastroenterol Clin Biol 33, 93-96.
Loffeld, A. and Marsden, J.R. (2005), Management of melanoma metastasis to
the breast: case series and review of the literature. Br J Dermatol 152,
1206-1210.
Luxman, D., Jossiphov, J., Cohen, J.R., Wolf, Y., and David, M.P. (1997), Uterine
metastasis from vulvar malignant melanoma. A case report. J Reprod Med 42,
244-246.
Martel, F., Grundemann, D., and Schomig, E. (2002), A simple method for
elimination of false positive results in RT-PCR. Journal of Biochemistry and
Molecular Biology 35, 248-250.

114

Mostofi, F.K., Davis, C.J., Sesterhenn, I.A., and Sobin, L.H. (1999), Histological
typing of urinary bladder tumours (Springer Berlin).
Mouawad, R., Sebert, M., Michels, J., Bloch, J., Spano, J.P., and Khayat, D.
(2010), Treatment for metastatic malignant melanoma: old drugs and new
strategies. Critical Reviews in Oncology/Hematology 74, 27.
Nuccitelli, R., Chen, X., Pakhomov, A.G., Baldwin, W.H., Sheikh, S., Pomicter,
J.L., Ren, W., Osgood, C., Swanson, R.J., Kolb, J.F., Beebe, S.J., and
Schoenbach, K.H. (2009a), A new pulsed electric field therapy for melanoma
disrupts the tumor’s blood supply and causes complete remission without
recurrence. Int J Cancer 125, 438-445.
Nuccitelli, R., Chen, X., Pakhomov, A.G., Baldwin, W.H., Sheikh, S., Pomicter,
J.L., Ren, W., Osgood, C., Swanson, R.J., Kolb, J.F., et al. (2009b), A new pulsed
electric field therapy for melanoma disrupts the tumor’s blood supply and causes
complete remission without recurrence. International Journal of Cancer 125,
438—445.
Nuccitelli, R., Pliquett, U., Chen, X., Ford, W., James Swanson, R., Beebe, S.J.,
Kolb, J.F., and Schoenbach, K.H. (2006), Nanosecond pulsed electric fields
cause melanomas to self-destruct. Biochemical and Biophysical Research
Communications 343, 351-360.
Pakhomov, A.G., Bowman, A.M., Ibey, B.L., Andre, F.M., Pakhomova, O.N., and
Schoenbach, K.H. (2009), Lipid nanopores can form a stable, ion channel-like
conduction pathway in cell membrane. Biochemical and Biophysical Research
Communications 385, 181-186.
Pakhomov, A.G., Kolb, J.F., White, J.A., Joshi, R.P., Xiao, S., and Schoenbach,
K.H. (2007a), Long-lasting plasma membrane permeabilization in mammalian
cells by nanosecond pulsed electric field (nsPEF). Bioelectromagnetics 28,
655-663.
Pakhomov, A.G., Shevin, R., White, J.A., Kolb, J.F., Pakhomova, O.N., Joshi,
R.P., and Schoenbach, K.H. (2007b), Membrane permeabilization and cell
damage by ultrashort electric field shocks. Archives of Biochemistry and
Biophysics 465, 109-118.

115

Perret-Court, A., Fernandez, C., Monestier, S., Millet, V., and Tasei, A.M. (2010),
Placental metastasis of melanoma: a new case and literature review. Ann Pathol
30, 143-146.
Piel, M., Nordberg, J., Euteneuer, U., and Bornens, M. (2001),
Centrosome-dependent exit of cytokinesis in animal cells. Science 291,
1550-1553.
Punda, M., Franceschi, M., Roncevic, S., Matesa, N., and Kusic, Z. (2010),
Intrathyroid metastasis of malignant melanoma: a case report. In Annual
Congress of the European Association of Nuclear Medicine, vol. 37, 452.
Ramakers, C., Ruijter, J.M., Deprez, R.H.L., and Moorman, A.F. (2003),
Assumption-free analysis of quantitative real-time polymerase chain reaction
(PCR) data. Neuroscience Letters 339, 62-66.
Rigel, D.S., Friedman, R.J., and Kopf, A.W. (1996), The incidence of malignant
melanoma in the United States: issues as we approach the 21st century. J Am
Acad Dermatol 34, 839-847.
Ritz, C. and Spiess, A.N. (2008), qpcR: an R package for sigmoidal model
selection in quantitative real-time polymerase chain reaction analysis.
Bioinformatics 24, 1549-1551.
Romeo, S., Sarti, M., Scarfi, M.R., and Zeni, L. (2010), Modified Blumlein
pulse-forming networks for bioelectrical applications. J Membr Biol 236, 55-60.
Ruijter, J., Ramakers, C., Hoogaars, W., Karlen, Y., Bakker, O., Van den Hoff, M.,
and Moorman, A. (2009), Amplification efficiency: linking baseline and bias in the
analysis of quantitative PCR data. Nucleic Acids Research 37, e45-e45.
Schmidt, J., Riechers, A., Stoll, R., Amann, T., Fink, F., Spruss, T., Gronwald, W.,
Konig, B., Hellerbrand, C., and Bosserhoff, A.K. (2012), Targeting Melanoma
Metastasis and Immunosuppression with a New Mode of Melanoma Inhibitory
Activity (MIA) Protein Inhibition. PLoS One 7, e37941.
Schoenbach, K.H., Hargrave, B., Joshi, R.P., Kolb, J.F., Nuccitelli, R., Osgood,
C., Pakhomov, A., Stacey, M., Swanson, R.J., White, J.A., et al. (2007),

116

Bioelectric effects of intense nanosecond pulses. Dielectrics and Electrical
Insulation, IEEE Transactions 1 4 ,1088-1109.
Shin, N.Y., Hong, Y.J., Kim, A.H., Shim, H.S., Nam, J.E., Lee, H.J., and Kim, M.J.
(2011), Diffuse interstitial infiltrative lung metastasis of malignant melanoma: a
case report. Korean J Radiol 12, 252-255.
Siegel, R., Naishadham, D., and Jemal, A. (2013), Cancer statistics, 2013. CA: A
Cancer Journal for Clinicians 63, 11-30.
Stoll, R., Renner, C., Buettner, R., Voelter, W., Bosserhoff, A.K., and Holak, T.A.
(2003), Backbone dynamics of the human MIA protein studied by 15N NMR
relaxation: Implications for extended interactions of SH3 domains. Protein
Science 12, 510-519.
Stoll, R., Renner, C., Zweckstetter, M., Bruggert, M., Ambrosius, D., Palme, S.,
Engh, R.A., Golob, M., Breibach, I., Buettner, R., et al. (2001), The extracellular
human melanoma inhibitory activity (MIA) protein adopts an SH3 domain-like
fold. The EMBO Journal 20, 340-349.
Takahashi, I., Sugimoto, S., Nunomura, M., Takahashi, A., Aida, T., Katoh, T.,
Abe, H., Kojima, H., and Inoue, K. (1990), [A case of cystic metastatic intracranial
amelanotic melanoma-analysis of findings in CT and MRI]. No To Shinkei 42,
1031-1034.
Thomas Vernier, P., Sun, Y., Marcu, L., Craft, C.M., and Gundersen, M.A. (2004),
Nanoelectropulse-induced phosphatidylserine translocation. Biophysical Journal
86, 4040-4048.
Toledano, H., Visee, C., Arroua, F., Rossi, D., and Bastide, C. (2009), Bladder
metastasis of malignant melanoma: a case report and review of literature. Prog
Urol 19, 139-141.
Tscheudschilsuren, G., Bosserhoff, A., Schlegel, J., Vollmer, D., Anton, A., Alt, V.,
Schnettler, R., Brandt, J., and Proetzel, G. (2006), Regulation of mesenchymal
stem cell and chondrocyte differentiation by MIA. Experimental Cell Research
312, 63-72.

117

Turner, S. and Sherratt, J.A. (2002), Intercellular adhesion and cancer invasion: a
discrete simulation using the extended Potts model. Journal of Theoretical
Biology 216, 85-100.
van Groningen, J.J., Bloemers, H.P., and Swart, G.W. (1995), Identification of
melanoma inhibitory activity and other differentially expressed messenger RNAs
in human melanoma cell lines with different metastatic capacity by messenger
RNA differential display. Cancer Research 55, 6237-6243.
Vinay, K., Abbas, A., and Fauston, N. (2004), Robbins and Cotran pathologic
basis of disease. New York: Saunders , 623-625.
Xiao, S., Guo, S., Nesin, V., Heller, R., and Schoenbach, K.H. (2011),
Subnanosecond electric pulses cause membrane permeabilization and cell
death. IEEE Trans Biomed Eng 58, 1239-1245.
Yeung, R.S. (1994), Management of recurrent cutaneous melanoma. Curr Probl
Cancer 18, 143-186.
Zhang, J., Blackmore, P.F., Hargrave, B.Y., Xiao, S., Beebe, S.J., and
Schoenbach, K.H. (2008), Nanosecond pulse electric field (nanopulse): A novel
non-ligand agonist for platelet activation. Archives of Biochemistry and
Biophysics 471, 240-248.
Zhu, N., Eves, PC., Katerinaki, E., Szabo, M., Morandini, R., Ghanem, G.,
Lorigan, P., MacNeil, S., and Haycock, J.W. (2002), Melanoma Cell Attachment,
Invasion, and Integrin Expression is Upregulated by Tumor Necrosis Factor a
and Suppressed by a Melanocyte Stimulating Hormone. Journal of Investigative
Dermatology 119, 1165-1171.

118

APPENDIX

CONVERSION OF G TO R P M

Some centrifuge machines only allow the adjusting of RPM instead of RCF.
Therefore, RCF was used to calculate the needed RPM (Equation 4).
RCF = 1.118 x 1CT5 x R x RPM2
where RCF is the Relative Centrifugal Force (g), R is the rotating radius (cm),
and RPM is revolutions per minute.
1. The rotating radius of the low speed centrifuge machine was 16 cm. The
required RCF was 125 x g.
v 125=1.118x10-5x1 6 xR P M 2. ,\RPM=836.
2. The rotating radius of the Spectrafuge machine was 6 cm. The required
RCF was 125xg.
v 125=1.118x10-5x 6 xR P M 2. ,\RPM=1365.

3. The rotating radius of the Spectrafuge machine was 6 cm. The required
RCF was 5000xg.
v 5000=1.118x10~5x 6 xR P M 2. ,\RPM=8634

(4)
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